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BACKGROUND: Event-Related Oscillations (EROs) have been linked to cognition 
and found to be abnormal in psychotic disorders. It is unclear if EROs abnormalities 
reflect genetic liability to psychosis, if they are markers of onset and/or progression of 
the disease. METHODS: 35 early psychosis and 44 chronic psychosis patients, 69 
unaffected first-degree relatives, 40 subjects with an 'at risk mental state' (ARMS) and 
76 healthy controls were included in this study. Subjects underwent 
electroencephalography recording during an auditory oddball task, a duration-deviant 
passive auditory oddball paradigm, and a paired-click paradigm, which elicit, 
respectively, selective attention, salience detection and sensory gating brain processes. 
Wavelet-based time-frequency analyses were conducted to extract single trial EROs. 
Relevant EROs clusters were identified by examining EROs condition effects, EROs 
associations with oddball task reaction time and EROs differences between patients and 
controls, through cluster-based t-tests and regression analysis. Composite EROs were 
compared between groups using ANOVA, regressed to test relationships between the 
three paradigms and associations with psychosis symptoms scores. RESULTS: 
Selective attention EROs were influenced by psychosis disease progression, salience 
EROs by disease chronicity and sensory EROs gating by disease onset. These three 
EROs groups were all influenced by psychosis genetic liability. Psychosis symptoms 
were predicted by sensory EROs gating and salience EROs in early and chronic 
patients, respectively. Salience EROs and EROs gating combined, predicted selective 
attention EROs in all groups, except in psychosis patients. First-degree relatives and 
ARMS subjects showed evidence of compensatory EROs changes. Salience EROs 
decreased with advancing age. CONCLUSIONS: In psychosis, attention-related EROs 
reflect genetic vulnerability, disease onset and progression, together with brain 
compensatory adaptations and ageing. 
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CHAPTER ONE – INTRODUCTION 
 
1.1 Neurodevelopmental and neurodegenerative models of 
schizophrenia 
 
The understanding of schizophrenia's etiopathology and natural course, which shape its 
clinical presentation and guide its treatment, can be viewed under two different 
perspectives: the neurodevelopmental and neurodegenerative models. The 
neurodevelopmental model of schizophrenia posits that this disease is the outcome of 
abnormalities in maturational processes, occurring in the brain long before the onset of 
symptoms, caused by genetic and environmental factors (Rapopport et al. 2012, Murray 
and Lewis 1987, Weinberger 1987). Patients show a neurodevelopmental lag, gradually 
falling behind, in cognitive ability, probably until early adulthood (Reichenberg et al. 
2010). In the neurodevelopmental model, genetic liability to psychosis plays a central 
role, particularly those genes involved in brain development. In order to unravel the 
complex genetics of psychiatric disorders, the concept of endophenotypes has been 
construed (Flint and Munafo 2014, Glahn et al. 2014, Kendler and Neale 2010, 
Turetsky et al. 2007, Cannon and Keller 2006, Gottesman and Gould 2003). 
Endophenotypes are disease associated objective measures, including 
neurophysiological, neuroanatomical, biochemical, endocrinological and 
neuropsychological parameters. They should reflect the action of susceptibility genes 
more directly than the disease phenotypical expression, increasing the power to identify 
those genes and also to understand the mechanisms whereby they influence psychiatric 
disorders. The criteria for evaluating a potential endophenotype are established, with 
some variations between authors. The trait should be associated with the disorder in the 
Chapter one - Introduction 
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general population, be more prevalent in unaffected relatives of affected individuals 
than in the general population, co-segregate with the disease in families, be heritable, be 
reliably measured, be stable and state-independent (i.e. it should be present in affected 
individuals even outside periods of acute illness or symptom exacerbation), its 
measurement should be non-invasive and economically feasible. This approach has 
been extensively applied to schizophrenia (Allen et al. 2009, Braff et al. 2007) with 
large ongoing multicentre studies (Greenwood et al. 2013, Calkins et al. 2007). 
 
With a different focus, the classic Kraepelin model of schizophrenia stressed that 
neurodegenerative changes take place after the onset of symptoms, with gradual 
decline in brain, cognitive and social functioning (Lieberman 1999). It has been argued 
that relapse in schizophrenia is linked with disease progression (Emsley et al. 2013). 
Neuroimaging studies indicate progressive neuroanatomical changes in schizophrenia, 
even though these may be confounded by other factors, including medication effects 
(Haijma et al. 2013, Bora et al. 2011, Chan et al. 2011, Olabi et al. 2011, Leung et al. 
2011, Ellison-Wright et al. 2008, Hulshoff and Kahn 2008, Wood et al. 2008). The 
neurodegenerative hypothesis is also supported by the evidence of better treatment 
response in first-episode schizophrenia patients, compared to chronic multi-episode 
schizophrenia (Kahn et al. 2008, Jäger et al. 2007, Lieberman et al. 1993, McEvoy et al. 
1991). Against this hypothesis, however, meta-analyses of longitudinal studies of 
cognition in schizophrenia have indicated there is no progressive cognitive impairment 
and that, in fact, improvement is possible after the onset of the disorder (Lewandowski 
et al. 2011, Szöke et al. 2008). It has been argued (Zipursky et al. 2012) that: 1) 
longitudinal studies indicate few patients show incremental loss of function that is 
characteristic of neurodegenerative disorders; 2) decreases in brain tissue volumes 
reported in neuro-imaging studies could be explained by the effects of antipsychotic 
Chapter one - Introduction 
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medication, substance abuse, effects of lifestyle or elevated glucocorticoid levels 
associated with chronic stress; and 3) the deterioration that occurs in some patients 
could reflect poor access or adherence to treatment, the effects of concomitant 
conditions, and social and financial impoverishment. 
The clinical staging model of psychosis (McGorry et al. 2006) makes the assumption 
that neurobiological deficits show progression and transgression of thresholds, in time, 
through different stages of psychosis. This is proposed to be a more refined form of 
diagnosis, which could promote early intervention and improve the logic and timing of 
therapeutic interventions. These interventions could be evaluated in terms of their 
ability to prevent or delay progression from earlier to later stages of disorder, and they 
could be selected on clear-cut risk/benefit criteria. This model identifies a critical 
period, the first 5 years after the first episode of psychosis. This early psychosis stage is 
considered non specific, with phenotypal overlap, variable prognosis and this group of 
patients can follow several diagnostic trajectories on follow up. In this context, 
biomarkers correlating with psychosis severity could allow us to stage the disease, 
provide insights into treatment and prognosis (Light et al. 2012, Luck et al. 2011). 
Moving the field even further, in recent years much research has been made on the 
psychosis high risk state (Fusar-Poli et al. 2013), trying to identify individuals at high 
risk of coming do develop a full blown psychotic episode. The attenuated psychosis 
syndrome, a syndrome characterized by sub-threshold psychotic symptoms, associated 
with a very significant increase in the risk of development of a full-fledged psychotic 
disorder (schizophrenia spectrum, psychotic mood disorder, and other psychotic 
disorders) within the next year, has been included as a nosological category in DSM-5, 
as a condition for further study (Tsuang et al. 2013). Operationalized diagnostic criteria 
have given rise to the ultra high risk (Yung et al. 2003), clinical high risk (Cornblatt et 
al. 2003) or at-risk mental state (ARMS; Yung et al. 1996) status. These criteria require 
Chapter one - Introduction 
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the presence of ‘attenuated’ psychotic symptoms, full-blown psychotic symptoms that 
are brief and self-limiting (Brief Intermittent Psychotic Symptom syndrome, BLIPS), or 
a signiﬁcant decrease in functioning in the context of a genetic risk for schizophrenia 
(Genetic Risk and Deterioration syndrome, GRD). Despite the operationalization of 
these diagnostic criteria and identification of other risk factors (Fusar-Poli et al. 2013, 
Mason et al. 2004), their positive predictive value in predicting transition to psychosis 
declined (Yung et al. 2007). There is evidence that early psychological and 
pharmacological interventions may improve outcomes (Stafford et al. 2013), however 
the evidence is still not conclusive and the risk-benefit ratio of for example starting 
antipsychotic treatment in the prodromal phase raises controversy (Weiser 2011). 
Again, the identification of biomarkers, in this case associated with a subsequent 
transition to psychosis, would be valuable in targeting treatment to those who require it. 
There are possible candidates: neuropsychological functioning in clinical high risk 
individuals has been shown to be significantly lower in those who progressed 
to psychosis, than in those who did not and was worst in the subgroup with a family 
history of psychosis (Seidman et al. 2010); individuals at high risk for psychosis show 
MRI alterations in regional gray matter volume regardless of whether they subsequently 
develop the disorder and in this population, reduced left parahippocampal volume has 
been specifically associated with the later onset of psychosis (Mechelli et al. 2011); 
 patterns of abnormalities in attention dependent (Van Tricht et al. 2011) and pre-
attentive (Hsieh et al. 2012) auditory event-related potentials, in subjects across 
different risk levels of psychotic disorders have been described.  
 
The endophenotype and neurodegenerative/progressive models are two approaches 
with, in the first instance, somewhat contradictory assumptions. The endophenotype 
model focuses on heritability, familial association, cosegregation and state-
Chapter one - Introduction 
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independence. Endophenotypes are regarded as constant traits, which are present at all 
clinical stages, even in the non clinical at risk state. State markers, on the contrary, 
should depend on the stage of the illness, intensity of symptoms, medication status and 
other clinical aspects. The distinction between endophenotypes and state markers may, 
however, not be so clear cut.  As an example, P300 ERP amplitude reduction has been 
shown in asymptomatic schizophrenia patients and unaffected relatives of patients; 
however, P300 amplitude deficits can also track symptoms fluctuation and show 
increase in magnitude with advancing chronicity of the disease, as reviewed below.  
 
1.2 The psychosis continuum 
 
In the last few decades, there has been a trend in diagnostic classification and research 
to focus on the broader category of psychosis, across the traditional Kraepelian 
diagnostic classifications, including schizophrenia and bipolar affective disorder. 
Abandoning the categorical approach in favour of a dimensional or continuous 
conceptualization has long been proposed (Crow 1990) and the latter has been 
integrated in DSM V (Barch et al. 2013). This is based both on the observations, in 
clinical practice, of a phenotypic overlap between the diagnostic categories, as well as 
on the available empirical data linking these disorders. Symptoms, psychosocial 
functioning, and familial lineage have been found to show considerable overlap across 
the schizophrenia, schizoaffective disorder and bipolar I disorder (Tamminga et al. 
2013). Common genetic liability between these disorders has been established 
(Craddock and Owen 2010, Lichtenstein et al. 2009, Murray et al. 2004, Cardno et al. 
2002). Schizoaffective disorder may bridge genetic liability to both a mood disorder and 
schizophrenia (Bramon and Sham 2001). Other aetiological risk factors, including 
preterm birth (Nosarti et al. 2012) may well act across these traditional diagnostic 
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boundaries. With regards to their neurophysiology, evidence suggests these disorders 
have both shared and specific abnormalities (Ethridge et al. 2012, Hamm et al. 2012, 
Thaker 2008). Schizophrenia and bipolar disorder patients share a similar cognitive 
impairment profile, but different degrees of deficits, where patients with schizophrenia 
do worse: the difference between the two groups seems to be more quantitative (degree 
of deficit) rather than qualitative (profile) (Vöhringer et al. 2013). A generic association 
between genetic risk for those disorders and MRI white matter volume reduction in the 
left frontal and temporoparietal regions has been reported (McDonald et al. 2004). 
Moreover, a meta-analysis comparing MRI abnormalities in schizophrenia and bipolar 
disorders found those abnormalities not to be diagnostically specific (Arnone et al. 
2009). There are ongoing efforts through multicentre studies to find intermediate 
phenotypes across psychotic disorders (Tamminga et al. 2013, Psychosis 
Endophenotypes International Consortium and the Wellcome Trust Case-Control 
Consortium 2, 2013). There is also overlap between non affective and affective 
psychosis treatments, such that antipsychotics are effective not just for schizophrenia 
but also bipolar disorder (Fountoulakis et al. 2012). Diagnostic category barriers have 
been cut across the schizophrenia diagnosis itself: The American Psychiatric 
Association, in their new classification of psychiatric disorders, the DSM V, abandoned 
the schizophrenia subtypes (paranoid, disorganized, catatonic, undifferentiated, and 
residual type), considering their limited diagnostic stability, low reliability and poor 
validity. According to APA, those subtypes did not appear to help with providing better 
targeted treatment, nor predicting treatment response (Tandon et al. 2013).  
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1.3 P300, MMN and P50 Event-Related Potentials (ERPs) in psychosis 
  
ERP biomarkers have several desirable properties to measure neural events underlying 
cognition, aiding to identify endophenotypes, defining treatment targets, evaluating new 
compounds in animals and in humans and for identifying individuals who are good 
candidates for early interventions or for specific treatments (Luck et al. 2011): (1) they 
provide a direct measure of electrical activity during neurotransmission; (2) their high 
temporal resolutions make it possible to measure neural synchrony and oscillations; (3) 
they are relatively inexpensive and convenient to record; (4) animal models are readily 
available for several ERP components; (5) decades of research has established the 
sensitivity and reliability of ERP measures in psychiatric illnesses; and 6) feasibility of 
large N (>500) multisite studies has been demonstrated.  
Abnormalities in the auditory ERP components, P300 (Turetsky et al. 2015, Bramon et 
al. 2004), Mismatch Negativity (MMN) (Light et al. 2015, Umbricht et al. 2005, 
Bramon et al. 2004) and P50 gating (Olincy et al. 2010, Patterson et al. 2008, Bramon 
et al. 2004) have been associated to schizophrenia (Turetsky et al. 2007, Van der Stelt 
and Belger 2007). They have also been implicated in bipolar disorder, although MMN 
impairment has been more specifically linked to schizophrenia (Thaker 2008).    
The auditory ERPs are believed to have specific functional significance, which can be 
associated to different brain processes that are impaired in psychosis and bear clinical 
significance (Turetsky et al. 2009). P300 can be elicited in the auditory “oddball” 
paradigm and is a brain response to task-relevant, context dependent, stimuli. In the 
classical experimental design, the subject is asked to attend to 2 different types of 
auditory stimuli, low Vs high frequency clicks, one which is frequent, the other rare and 
is instructed to respond to the rare stimulus (target) by pressing a button. This generates 
an ERP with a positive polarity wave approximately 300 ms post stimulus, the P300 
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wave. It is thought to index stimulus significance - the degree of selective attention 
allocated to the eliciting stimuli and memory updating operations in the brain (Polich 
2007, Roth and Cannon 1972, Sutton et al. 1965). MMN is elicited in a “passive” 
auditory oddball paradigm, to infrequent deviant stimuli. The subject is resting or 
involved in the attentive processing of visual information, but not the auditory stimuli, 
hence the “passive” designation. It is essentially an automatic, pre-attentive brain 
response and it is believed to reflect the comparison process between the current deviant 
acoustic input and a sensory memory trace representing the physical features of the 
preceding standard stimuli. It represents the initial stage of the alerting and redirecting 
of the organism's attention towards salient or deviant, potentially significant, auditory 
stimulus events in the environment (Todd et al. 2011, Näätänen et al. 2009, Shelley et 
al. 1991). The P50 is elicited in a auditory dual-click or conditioning-testing task, where 
paired clicks are presented separated by an interval of 500 ms. The averaged ERP 
produces a response approximately 50 ms post stimulus, of positive polarity, the P50 
wave. The relative decrease of the P50 wave to the second click (S2) compared with the 
first (S1), the S2/S1 ratio, has been used as a measure of sensory gating. This ratio is 
believed to reflect inhibitory mechanisms, an ability to inhibit intrinsic responses to 
redundant stimuli, that is impaired in schizophrenia (Patterson et al. 2008, Adler et al. 
1982). 
Arguably, attention and its key mechanism of salience detection (Corbetta and Shulman 
2002), core elements of schizophrenia etiopathogenesis (Kapur 2003), modulate brain’s 
reactions across the oddball task (Coull 1998), passive oddball (Todd et al. 2012) and 
gating paradigms (Rosburg et al. 2009, Potter et al. 2006). Those auditory ERPs 
represent different brain functions, which are collectively integrated in a multi-stage 
process involving bottom-up gestalt grouping primitives, auditory memory, attention 
and other forms of top-down control (e.g. motivational significance reflected in Error-
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Related Negativity), that ultimately leads to the extraction of signal from noise and 
separation of foreground from background, in auditory scenes analysis (Fritz et al. 
2007). Auditory attention theories underline brain's ability to engage in the processing 
of relevant stimuli, whilst simultaneously filtering out irrelevant stimuli and shift its 
focus following variations in the environment, sometimes alluded to as the "cocktail 
party" phenomenon (Shinn-Cunningham 2008, Fritz et al. 2007, Jaaskelainen et al. 
2007). Perceptual objects compete for the attention focus, based on their inherent 
salience and the influence of top-down attention, the latter favouring objects with 
desired perceptual features (Shinn-Cunningham 2008, Fritz et al. 2007). Several 
mechanistic explanations for auditory attention have been put forward, including, at the 
auditory cortex level, center-excitation surround-inhibition, that is, the enhancement of 
neural sensitivity to some sound features with simultaneous inhibition of neural 
sensitivity to adjacent features (Jaaskelainen et al. 2007). At the neuronal level, 
stimulus-specific adaptation, the decline over time of neuronal responses to similar 
stimuli, may underlie auditory novelty detection (Ulanovsky et al. 2003). 
 
1.3.1 Psychosis neurophysiological traits Vs progressive abnormalities 
  
Each of the P300, MMN and P50 ERPs has been used according both to the 
neurodevelopmental and neurodegenerative conceptual approaches. One, looking at 
their quality as "trait" markers (in relation to psychosis genetic vulnerability, as an 
endophenotype) and the other as "state" markers (in relation to the clinical presentation 
of the illness, namely illness duration and symptoms severity).  
Studies comparing P300 amplitude at Pz in samples of healthy controls, prodromal, first 
episode and chronic schizophrenia patients (Van Tricht et al. 2011, Umbricht et al. 
2006, Van der Stelt et al. 2005, Brown et al. 2002, Demiralp et al. 2002, Salisbury et al. 
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1998), together with family/twin schizophrenia studies (Groom et al. 2008, Hall et al. 
2006, Price et al. 2006, Bramon et al. 2005, Winterer et al. 2003, Turetsky et al. 2000, 
Frangou et al. 1997), have found evidence for the trait hypothesis, however disease 
dependence (de Wilde et al. 2008) and progressive amplitude reduction have also been 
suggested by other studies (Chen et al. 2013, Ozgurdal et al. 2008, Martin-Loeches et 
al. 2001, Mathalon et al. 2000). Moreover, P300 amplitude has been shown to track the 
variation in severity of psychopathology (Turetsky et al. 2014, Mathalon et al. 2000). 
There are tentative associations between the P300 and candidate genes for psychosis, 
including DISC1 (Shaikh et al. 2013, Blackwood et al. 2001), Neuroregulin 1 (Bramon 
et al. 2008), however the case of the COMT Val158Met polymorphism illustrates the 
pitfalls in drawing conclusions about genetic associations between the P300, candidate 
genes and schizophrenia (Bramon et al. 2006). 
MMN has been found associated to progressive brain abnormalities in schizophrenia 
(Jahshan et al. 2012, Magno et al. 2008, Umbricht et al. 2006, Brockhaus-Dumke et al. 
2005), correlating in one study with left Heschl gyrus atrophy (Salisbury et al. 2007). A 
reduction in MMN amplitude was also found in adolescents from the general population 
(non clinical sample) with psychotic symptoms, a very early stage of risk (Murphy et al. 
2013) and subjects with at-risk mental state (Higuchi et al. 2013, Hsieh et al. 2012). 
Most studies report little or no genetic influence on MMN (Magno et al. 2008, Hall et 
al. 2006, Price et al. 2006, Bramon et al. 2004), although the opposite has also been 
found (Michie et al. 2002). A MMN frontal amplitude reduction was associated with the 
presence of the COMT (108/158) Met allele on the single intact chromosome 22 of 
individuals with microdeletions at the chromosome 22q11.2, known to be at high risk 
for schizophrenia (Baker et al. 2005). 
Brockhaus-Dumke et al. (2008) compared P50 S2/S1 gating in samples of prodromals, 
first episode and chronic schizophrenia patients, who were all unmedicated, finding 
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reduced gating to be present already in the early stages of schizophrenia, however this 
deficit was more pronounced in chronic schizophrenia patients. This gradient was 
corroborated in another study including subjects in pre-psychotic state (Hsieh et al. 
2012). There is evidence for a genetic link between the gating of the P50 ERP and 
schizophrenia (Hall et al. 2006, Price et al. 2006, Louchart-de la Chapelle et al. 2005, 
Clementz et al. 1998, Siegel et al. 1984), as well as bipolar disorder (Hall et al. 2008). 
A single nucleotide polymorphism in the 15q14 gene CHRNA7 5’core promoter has 
been associated with P50 suppression deficits (Freedman et al. 2003, Leonard et al. 
2002). Methodological issues have however contributed to mixed findings with regards 
to the reliability of the P50 gating (Patterson et al. 2008) and its viability as an 
endophenotype (Light et al. 2012, De Wilde et al. 2007, Greenwood et al. 2007). N100 
suppression in the same paradigm has been suggested as perhaps an alternative more 
robust measure (Brockhaus-Dumke et al. 2008, Turetsky et al. 2008).  
In literature reviews (Javitt et al. 2008, Turetsky et al. 2007), P300 and P50 have been 
considered to exhibit deficits in both schizophrenia patients and unaffected family 
members, showing strong evidence of heritability, whereas MMN has stronger evidence 
as a state marker.  
 
1.4 From ERPs to Event Related Oscillations (EROs) 
 
In the last decade, brain oscillations in the EEG corresponding to patterns of brain 
rhythms (with different frequencies) have received great interest in a broad field of 
research and been shown to play a crucial role in neuronal synchronization, linking 
single-neuron activity to behaviour (Buzsaki and Draguhn 2004). Oscillations in the 
beta and gamma range establish synchronization with great precision in local cortical 
networks (Gray et al. 1989), whereas lower frequencies preferentially establish 
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synchronization over longer distances (von Stein et al. 2000). Event related brain 
oscillations (EROs) correspond to the changes in the frequency power spectrum of the 
ongoing EEG triggered by events and are correlated with different aspects of cognition 
including attention and memory (Başar and Güntekin 2008). Methods of spectral 
decomposition of the EEG, time-frequency analysis, are now well established, (Roach 
and Mathalon 2008) and time-frequency analysis provides information not only on the 
magnitude of the oscillations but also on their phase. The instantaneous phase of an 
oscillation refers to where a specific time point falls, within the cycle of the oscillation, 
it adds to the information from its spectral power, because it is independent of signal 
amplitudes. Intertrial coherence is a measure of phase locking for a single electrode, 
between time locked responses across trials (Delorme and Makeig 2004).   
EROs can be further discriminated between two types: phase locked (evoked) or non 
phase locked (induced) to the eliciting event. The analysis of induced oscillations 
requires single-trial analysis whereas evoked oscillations can be obtained from the 
averaged ERP responses. This distinction provides additional information to the 
conventional time-voltage analysis of the ERP, which by averaging single trial EEG 
activity eliminates the non-stimulus-phase-locked activity. Broadly, induced oscillations 
are thought to reflect top-down brain activity, whereas evoked oscillations are thought 
to be stimulus driven and induced gamma band activity, in particular, has been 
implicated in several cognitive functions (Taullon-baudry 1996). Brain oscillations 
show cross-frequency coupling, which may serve as a mechanism to transfer 
information from large-scale brain networks operating at behavioral timescales to the 
fast, local cortical processing required for effective computation and synaptic 
modification, thus integrating functional systems across multiple spatiotemporal 
scales (Lisman and Jensen 2013, Canolty and Knight 2010). In a seminal study by 
Lakatos et al. (2008), during a visual attention task, delta phase was found to determine 
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power in higher-frequency (gamma) activity in the primary visual cortex and this 
coupling was inversely correlated with reaction times (Lakatos et al. 2008). Different 
methods have been proposed to measure this phenomenon, also referred to as nested 
oscillations (Penny et al. 2008, Cohen 2008, Jensen and Colgin 2007). 
 
1.4.1 EEG time-frequency analysis in schizophrenia 
 
EEG spectral abnormalities have consistently been found on the resting EEG in 
schizophrenia and a pattern profile of increased slow waves, decreased alpha and 
increased beta activity has emerged (Siekmaier and Stufflebeam 2010, Boutros et al. 
2008). Schizophrenia patients’ relatives also exhibit increased beta activity in resting 
state, suggesting excessive high-frequency EEG activity may serve as an 
endophenotype that reflects cortical expression of genetic vulnerability for 
schizophrenia (Narayanan et al. 2014, Venables et al. 2009). 
The study of Event related oscillations (EROs) in schizophrenia and other psychiatric 
disorders has received increasing attention (Basar and Guntekin 2013, Moran and Hong 
2011, Uhlhaas and Singer, 2010; Roach and Mathalon, 2008; Van der Stelt and Belger 
2007). Literature findings on EROs associated to cognitive abnormalities in 
schizophrenia, for each of the commonly analyzed frequency bands, were summarized 
as follows by Ulhaas et al. (2008): 
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The role of delta oscillatory responses in cognition and their impairment in different 
psychiatric disorders was not considered by Ulhaas et al. (2008), but reviewed more 
recently by Guntenkin and Başar (2015): these authors linked those brain oscillations to 
attentional and decision making processes and concluded that a deficit in delta 
oscillations may be a general electrophysiological marker for cognitive dysfunction. 
Gamma oscillations have received particular attention, because of their putative role in 
higher cognitive processes such as object representation, attention and memory 
(Herrmann et al. 2010, Tallon-Baudry 2009). However, the ability to reliably measure 
this frequency band oscillations from the scalp EEG, due to the interference of 
microsaccades artifacts, has generated controversy (Yuval-Greenberg et al. 2008). 
The current understanding is that different EROs time-frequencies reflect distinct brain 
functions and may be impaired by different disease mechanisms, moreover EROs 
interact across frequencies, therefore measuring and integrating multiple EROs is 
necessary in order to unravel schizophrenia complex neurophysiological abnormalities 
(Basar 2013, Moran and Hong 2011, Uhlhaas and Singer 2010, Roach and Mathalon 
2008, Van der Stelt and Belger 2007).   
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Several studies have tried to make a bridge between neurophysiological markers and 
clinical presentation in schizophrenia. Positive psychosis symptoms were correlated 
with enhanced amplitude and phase synchronization of evoked and induced 
beta/gamma-band activity (Spencer et al. 2008, Lee et al. 2003), whereas negative 
symptoms were related to both enhanced (Spencer et al. 2004) and reduced high-
frequency oscillations (Lee et al. 2003). EROs have also been associated to 
schizophrenia cognitive deficits. Patients showed reduced theta oscillations, involved in 
mediating frontal lobe activity and functions related to enhanced executive control, 
under varying working memory load (Schmiedt et al. 2005). Higher cognitive control 
demands were associated with increases in induced γ-band activity in the prefrontal 
areas of healthy subjects, but that control-related modulation of prefrontal γ-band 
activity was absent in schizophrenia subjects (Cho et al. 2006). Haenschel et al. 2009 
found working memory deficits in schizophrenia patients to be associated with 
impaired oscillatory activity during all phases of the memory task and 
the cortical storage system in patients to reach its capacity limit at lower loads. 
Moreover, impaired cognitive control-related gamma cortical oscillatory activity was 
found to be present at the first psychotic episode in schizophrenia, and this was 
independent of medication status (Minzenberg et al. 2010). 
Although the power and synchrony of specific neural oscillations are decreased in 
schizophrenia, evidence of greater high-frequency activity during the resting state, as 
well as during auditory and visual sensory processing in brain sensory areas of patients 
with hallucinations compared to those without (Spencer et al. 2008, Lee et al. 2003), 
suggests that the cortical areas involved in generating hallucinations might be 
hyperexcitable (Uhlhaas and Singer, 2010). 
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Several neurotransmitter systems that are abnormal in schizophrenia are also involved 
in the generation and synchronization of cortical oscillations. GABAergic inhibitory 
interneurons are of particular importance and have been proposed to have a role in 
entraining cortical pyramidal cells (Cobb et al. 1995). There is evidence 
that GABA neurotransmission is altered in schizophrenia, thus resulting in decreased 
strength of inhibitory connections, impairing neural synchrony and cognitive function 
(Gonzalez-Burgos and Lewis, 2008). Neural oscillations are also under glutamatergic 
control and the administration of ketamine to healthy subjects appeared to mimic some 
aspects of neural oscillatory deficits in schizophrenia, showing an opposite effect on 
scalp-recorded gamma Vs low-frequency oscillations (Hong et al. 2010). Dopamine is a 
neurotransmitter that has traditionally been implicated in the pathophysiology of 
schizophrenia. However, evidence for a direct impact of dopaminergic transmission on 
neural oscillations in schizophrenia is lacking. Nevertheless, dopamine (through 
dopamine D4 receptors) and Neuroregulin (NRG-1), which has been identified as a risk 
gene for schizophrenia, have been found to synergistically modulate gamma oscillations 
in the prefrontal cortex and hippocampus (Furth et al. 2013). 
 
1.4.2 Oddball task, passive oddball and paired-click paradigms EROs 
in schizophrenia 
 
In the auditory oddball target detection paradigm, used to elicit the P300 ERP 
component, schizophrenia patients show power reductions in delta and theta bands and 
this is associated with decreased P300 amplitude (Doege et al. 2009, Ford et al. 2008, 
Roeschke et al. 1997). Gamma synchrony was found to predict the P300 component in 
controls, but not schizophrenia patients (Ford et al. 2008). This disease was also 
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associated with impaired parietal event related alpha (Higashima et al. 2007) and beta 
(Fujimoto et al. 2012) attenuation in the auditory oddball task. 
In the passive oddball paradigm, dependence of MMN amplitude on theta band 
oscillations has been shown in healthy subjects (Fuentemilla et al. 2008). Slow waves 
power in the resting EEG of schizophrenia patients was inversely correlated to MMN 
(Kirino and Inoue 1999) and MMN theta-alpha range oscillations were abnormally 
enhanced in schizophrenia patients (Hong et al. 2012). 
In the paired-click paradigm, schizophrenia patients show reduced gating of the 
theta/alpha frequency bands (Hong et al. 2008), EROs that contribute to the P50 
component amplitude (Brockhaus-Dumke et al. 2008, Jansen et al. 2004). Others have 
found abnormalities in faster, beta/gamma (Brenner et al. 2009, Hong et al. 2004, 
Clementz et al. 1997) EROs. Phase synchronization (2-12Hz range) deficits, in response 
to the conditioning stimulus and impaired correlation between phase synchronization 
and the N100 were also described (Jansen et al. 2004). Of note, ERPs may arise both by 
amplitude modulation and/or phase resetting of ongoing brain oscillations, in different 
frequency bands, however the proportion of the contribution of each of the two 
mechanisms is generally not entirely clear (Sauseng et al. 2007).  
 
Some studies have looked at the suitability of brain EROs as schizophrenia 
endophenotypes, with encouraging results. The early auditory evoked gamma-band 
response (Hall et al. 2011, Leicht et al. 2011, Leicth et al. 2010) and theta-alpha 
frequency EROs gating (Hong et al. 2008) were found abnormal both in schizophrenia 
patients and in their first-degree relatives. Few studies have yet looked at the 
associations between EROs and psychosis candidate genes in clinical samples of 
patients. One study found no association between noise power in the gamma band and 
Neuregulin gene variants (Diez et al. 2014). In healthy subjects, a modulation of evoked 
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gamma activity, during an auditory target detection paradigm, by DRD4 and DAT1 
polymorphisms, but not by COMT polymorphisms, has been described (Furth et al. 
2013, Demiralp et al. 2007). Of note, the same polymorphisms had no influence on P50, 
N100, or P300 amplitudes or latencies (Demiralp et al. 2007). 
 
1.5 Combining neurophysiological paradigms to characterize psychosis 
 
It has can be argued that combining different neurophysiological paradigms on the same 
sample of patients is potentially advantageous because they can complement each other 
and characterize the population more accurately (Turetsky et al. 2009, Price et al. 
2006). There have also been reports of associations between MMN-P300 (Gjini et al. 
2010, Leitman et al. 2010) and P50 gating-MMN (Gjini et al. 2010, Kisley et al. 2004) 
deficits in schizophrenia. A combined ERP study on schizophrenia twins, allowed to 
compare the genetic correlations between P300, P50 ratio, MMN and phenotypical 
disease expression (Hall et al. 2006).  Although the 3 auditory paradigms have different 
theoretical underpinnings and are likely to tap onto different neurobiological 
mechanisms, combined they could better capture the polygenic nature of psychotic 
illnesses and increase diagnostic sensitivity and specificity. By being relatively 
independent, they may help to unravel the heterogeneity of physiopathological 
mechanisms, deficits, genetic and non genetic pathways in schizophrenia. 
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1.6 Aims and hypothesis  
 
Overall, there is strong evidence to suggest that oscillatory brain activity underlies 
perceptual and cognitive processes, which are themselves affected in psychosis. Event 
related brain oscillations may complement conventional ERPs in measuring abnormal 
brain dynamics. Because EROs can be quantified reliably, they may become valuable 
diagnostic markers, endophenotypes for genetic studies, an aid to staging disease and/or 
guiding treatment.  
Hence, the object of my study is the broad band spectral EEG power, extracted from the 
brain responses in the auditory oddball task, passive oddball and paired-click 
paradigms. Three main hypothesis are tested:  
1. Psychosis patients exhibit deficits in auditory attention-related EROs when 
compared to controls; 
2. First-degree relatives of psychosis patients show abnormal auditory attention-
related EROs when compared to controls, indicating that these EROs are 
markers of genetic vulnerability to psychosis; 
3. There is an increasing gradient in the magnitude of auditory attention-related 
EROs abnormalities, indicating progression of disease from ARMS subjects, 
through early psychosis patients to chronic patients. 
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Chapter Two – Methodology 
 
2.1 Study Sample 
 
The overall study sample, outlined in Table 2.1a, contains 35 patients with early 
psychosis, 44 patients with chronic psychosis, 69 unaffected first-degree relatives, 40 
ARMS individuals and 76 unrelated controls with no history of psychosis. From this 
sample, I selected sub-samples for analysis, based on the availability of the EEG data. 
An overview of this process and the various samples investigated in the course of this 
thesis is presented in Figure 2.1a.  
The vast majority of patients included in this study had schizophrenia, schizoaffective 
disorder or another psychotic disorder (Table 2.1a), however a small number of bipolar 
disorder patients were also included, if the patient had a lifetime DSM-IV diagnosis of 
bipolar affective disorder type-1 with clear psychotic features (experiencing 
hallucinations and/or delusions at some point during their symptom exacerbation). All 
but 6 psychosis patients were medicated, the majority with an antipsychotic or a 
combination of antipsychotic + mood stabilizer/antidepressant (Figure 2.1b).  
Most participants (controls, ARMS and early psychosis patients) were recruited 
individually, but part of the chronic patients and relatives groups were recruited as part 
of a family study. Of the 264 participants, 181 (68.56%) were singletons, 58 (21.97%) 
were part of families with two members in the study, 21 (0.08%) were in three-person 
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Table 2.1b | Breakdown of clinical and demographic characteristics of 
psychosis patients 




N 35 44  
♀ : ♂  (% Male) 9 : 26 (74%) 11 : 33 (75%) n.s 
Mean Age (SD) 24.9 (4.1) 
 
41.4 (11.3) *** 
 
t (77) = 
8.2, 
p<0.001 
Tobacco2 –  
Non-Smokers : Smokers  
(% Smokers) 
9 : 25 (74%) 18 : 25 (59%) 
 
n.s. 


















DSM-IV Diagnosis (n) 
Schizophrenia (22) 
Bipolar Disorder, type 1 (5) 
Schizophreniform Disorder 
(3) 
Acute and transient psychotic 
disorder (3) 
Schizoaffective Disorder (1) 
Major depressive disorder, 
with psychotic symptoms (1) 
Schizophrenia (35) 
Schizoaffective Disorder (6) 








Positive (SD) 10.3 (3.9) 12.1 (4.7) * 
 
t (68) = -2.1, 
p = 0.04 
Negative (SD) 18.2 (8.3) 15.0 (7.6) n.s 
General (SD) 29.3 (8.2) 26.5 (8.6) n.s 
Total (SD) 57.8 (17.8) 53.9 (18.1) n.s 
No data was available for the chronic patients sample on age at onset, duration of illness, nor number of 
hospitalizations. PANSS data was available for 33 early psychosis patients and 37 chronic psychosis patients. * 
and *** indicate significant differences from the early psychosis group at p<0.05 and p<0.001 respectively. n.s 
indicates statistically non significant. Group compasisons here are unajusted for multiple comparisons. 





Figure 2.1b Patients group medication profile 
 
2.2 Recruitment of early psychosis patients 
 
Patients were eligible to enter this group if they were aged between 18-35 years old, had 
a DSM-IV diagnosis of a psychotic disorder (table 2.1a), an onset of psychotic 
symptoms less than 5 years previously and were able and willing to give informed 
consent in order to enter the study. They were recruited from the Lambeth early onset 
(LEO) service at the South London and Maudsley NHS Foundation Trust, both from the 
inpatient unit and community team.  
 
2.3 Recruitment of chronic patients and their first-degree relatives 
 
Families with one or more affected member were recruited by direct contact with 
mental health charities such as Rethink (formerly the National Schizophrenia 
Fellowship) and MIND (The National Association for Mental Health), and a wide 
variety of mental health service user groups across Greater London. Advertisements in 
the form of posters or short articles were also placed in the newsletters of these groups, 
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posted on a number of online forums for people with mental health issues and displayed 
inside a number of mental health care units. Patients selection criteria in this group 
differed from the early psychosis sample in that there was no maximum age limit and 
there was a minimum 5 years’ duration of illness. 
 
2.4 Recruitment of ARMS subjects 
 
The 40 individuals of the ARMS psychosis group had an ‘at risk mental state’ (ARMS) 
according to criteria established by Yung and colleagues. This includes people with sub-
clinical ‘attenuated’ psychotic experiences, individuals with psychotic symptoms of 
insufficient duration to reach a diagnosis (‘brief limited intermittent psychotic 
symptoms’ known as BLIPS), subjects with schizotypal personality disorder, or those 
with a first-degree relative with psychosis and who are experiencing a significant 
decline in function (Yung et al. 2005). ARMS subjects were recruited through the 
clinical service "Out-reach and Support In South London" (OASIS). None of the ARMS 
were taking antipsychotics at the time of EEG testing and the majority were 
antipsychotic naive. 
 
2.5 Recruitment of healthy controls 
 
Healthy controls were recruited from the community via advertisements in the local 
press (The Evening Standard, South London Press and The Metro) and through the 
newly created MindSearch database of controls at the Institute of Psychiatry. All 
volunteers for the study were compensated for their travel expenses and for their time 
spent undertaking the study. Participants gave written informed consent to enter the 
study. My research was approved by the Institute of Psychiatry Ethical Committee 
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(study references 038/00, 285/01, 011/99) and the Multi-Centre Research Ethics 
Committee (MREC reference 01/06/06). 
 
2.6 Study inclusion and exclusion criteria 
 
Participants were of mixed ethnic backgrounds, including caucasian and black ethnicity. 
Exclusion criteria were the presence of a neurological disorder or organic brain disease, 
head injury that resulted in loss of consciousness for a period longer than 10 minutes, or 
a DSM-IV diagnosis of alcohol or substance dependence in the 12 months prior to 
participation. Patients had a DSM-IV diagnosis of a psychotic disorder or mood 
disorder with psychotic symptoms. Controls had no personal or family history of 
psychosis, including schizophrenia, schizoaffective or bipolar disorders. History of a 
non-psychotic psychiatric disorder such as depression was not an exclusion factor, 
provided controls or 1st-degree relatives had recovered and not taken any psychotropic 
medication during the prior 12 months.  
 
2.7 Clinical and socio-demographic Assessments 
 
2.7.1 Screening 
All participants were screened using a telephone interview to ensure they met the 
criteria for the study before being invited to attend. Details of the study and what they 
were to expect during their visit were given orally to the individual or key family 
member. These were also provided again in printed form along with a letter confirming 
their appointment. Copies of all information given to the participants and the 
questionnaires they were required to complete can be found in appendix one. 
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2.7.2 Clinical assessments 
All new participants underwent a clinical assessment by a psychiatrist (Dr Elvira 
Bramon, Dr Miguel Constante or Dr Anirban Dutt). A structured diagnostic interview 
using the Schedule for Affective Disorders and Schizophrenia-Lifetime version (SADS-
L) (Endicott and Spitzer 1978) was completed to enable a DSM-IV diagnosis to be 
reached. Medical records were consulted where available if any uncertainty remained 
concerning diagnosis. The Positive and Negative Syndrome Scale (PANSS) (Kay et al. 
1987) was also completed by the clinician during the assessment. 
 
2.7.3 Family history 
The Family Interview for Genetic Studies (FIGS) (Nurnberger et al. 1994) was used to 
assess family history of mental illness and acquire information on family members not 
available for interview. The unaffected mother or father was the primary informant for a 
family and controls reported their own family history. 
 
2.7.4 Further assessments  
Information on handedness, educational history, and current nicotine, alcohol and illicit 
drug use was collected verbally at initial screening interview and on day of participation 
by both interview and questionnaire.  
 
2.8 Recording of EEG 
 
New recordings undertaken as part of my data collection were carried out at the 
Neurophysiology Laboratory in the Psychosis Centre of the Institute of Psychiatry, 
King’s College London. Previously recordings by my colleagues were carried out either 
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in the same lab, or at the Electrophysiology Laboratory inside The Eric Byers Magnetic 
Resonance Suite of Mapother House. As part of the research protocol, subjects were 
always requested not to smoke at least 30 minutes before data collection (Adler et al., 
1993). EEG data was recorded using a 40-channel Quik-Cap electrode cap positioned 
according to the 10/20 International System as shown in Figure 2.8a, referenced to 
linked mastoids and grounded at Fpz, a SCAN NuAmps ExpressTM 40-channel 
monopolar digital amplifier and SCAN software package version 4.3 (Compumedics 
Neuroscan, Texas, USA). Eye movements and blinking were recorded from electro-
oculogram (EOG) electrodes activity placed at four electrodes performing vertical and 
horizontal EOG recording in bipolar montage, as shown in Figure 2.8b. To prepare 
these areas and the mastoids before the placement of electrodes, abrasive gel was gently 
applied to the skin (NuPrep Abrasive Skin Prepping Gel, D.O Weaver and Co. 
Colorado, USA), and this was then cleansed with an alcohol swab (70% Isopropyl 
Alcohol Alcotip Swab, Universal Hospital Supplies Ltd., UK). This process reduces the 
impedance between the surface of the skin and the conductive gel by removing makeup, 
skin oil and dead skin cells. Electrode impedances were below 5 kΩ. Data was 
continuously digitised at 1000 Hz with a digital 0.1-100 Hz band pass filter (24 
dB/octave roll-off).  
 




Figure 2.8a The 10/20 International System for electrode placement 
 




RIGHT EYE CHANNEL 
(HEOGR/X4)
 
Figure 2.8b Placement of electro-oculogram (EOG) electrodes at right eye 
 
Stimuli were generated and presented using the STIM stimulus presentation system 
(Compumedics Neuroscan, Texas, USA) and delivered though intra-aural earphones 
(ER3-14A Eartips for ER-3 and ER-5, Etymotic Research Inc. Illinois, USA). Each 
recording session lasted approximately 45 minutes and the neurophysiological 
paradigms detailed below were carried out in this order: 1st - paired-clicks, 2nd auditory 
oddball task and 3rd. passive oddball (these were followed by recording of the resting 
EEG and PPI paradigm, which were not subject of study in this thesis). Participants 
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were seated in a comfortable chair, requested to fixate a point on the desk in front and 
keep their eyes open throughout the testing. While the equipment used in the acquisition 
of the EEG data had minor changes between the two laboratories used, the stimulation 
paradigms remained the same. A detailed description of the specifics of the different 
laboratories and the changes in data collection methodology is contained in appendix 
two. 
 
2.9 Oddball task paradigm 
 
The auditory oddball task (Bramon et al. 2005; Schulze et al. 2008) consisted of one 
block of four hundred 80 dB, 20-msec tones, with a 2 second (±0.2 second) inter-
stimulus interval presented through bilateral intra-aural earphones. 80% of the tones 
were ‘non-targets’ of 1000 Hz and 20% were ‘targets’ of 1500 Hz, in a random 
sequence. Subjects were instructed to press a button with their preferred hand in 
response to target tones only. Reaction time (RT) was measured as the button press 
median response latency to target tones, in milliseconds. Only trials with correctly 
identified target tones were used for later EROs/ERPs analysis.  
  
2.10 Passive oddball paradigm 
 
The passive oddball paradigm consisted of three blocks of 400 binaural 80-dB stimuli 
(0.3 sec inter-stimulus interval) per block, with 85% standards (1000 Hz, 25 ms, 5-ms 
rise/fall time) and 15% duration deviants (1000 Hz, 50 ms duration, 5 ms rise/fall time) 
(Bramon et al. 2004). Subjects were instructed to remain still and quiet throughout the 
test, to keep their eyes open and disregard the sounds presented to them.  
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2.11 Paired-click paradigm 
 
The paired-click paradigm consisted of four or five blocks of 30 pairs of conditioning 
(S1) and test (S2) clicks (Schulze et al. 2007; Hall et al. 2008). S1 and S2 clicks were of 
1 ms duration and separated by 500 ms. Intertrial intervals between click pairs were 10 
seconds. Subjects were instructed to avoid blinking during the click presentations. 
Stimulus intensity was adjusted individually to 43 dB above the subject's hearing 
threshold.  
 
2.12 Common EEG preprocessing to all paradigms 
 
Data analysis was performed offline using the Matlab-based FieldTrip toolbox 
(http://fieldtrip.fcdonders.nl/). Before time-frequency or ERP analysis, the continuous 
EEG was segmented into large epochs (–3100 to 2500 ms) in order to allow 
measurement of low frequency EROs in the observation intervals and minimize edge 
effects. Artefact rejection was performed to exclude data segments containing eye 
blinks, muscle artefacts and amplitudes exceeding +/- 100 μV. Line noise removal was 
performed at 50Hz using a discrete Fourier transform. These artefact-free epochs were 
then used in two different processing pipelines, for the purpose of either time-frequency 
or ERP analysis, as detailed below. 
 
2.13 ERP analyses methods 
 
For the purpose of P300 ERP analysis, the EEG was digitally filtered (0.05–40 Hz) and 
epochs were baseline corrected (–200 to 0 ms), averaged to yield the target ERP 
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waveforms. P300 amplitude was measured at Pz, using a computer algorithm to 
calculate peak (between 250 to 450ms) to baseline difference. P300 latency was 
measured as the post-stimulus latency to P300 peak, in milliseconds. 
For the purpose of MMN ERP analysis, the EEG data was filtered (0.03–40 Hz), and 
baseline corrected (–50 to 0 ms). MMN was extracted by subtracting the averaged 
waveforms for the standard stimuli from those for the deviant stimuli. The amplitude of 
the Mismatch Negativity waveform was measured at Fz, calculating the difference 
between mean MMN (130 to 190ms) and MMN baseline (-50 to 0ms), using a computer 
algorithm. 
For the purpose of P50 ERP analysis, the EEG signal was filtered (10Hz high-pass 
filter), and corrected for baseline values (–50 to 0 ms). Epochs were averaged separately 
for the S1 and S2. P50 peak amplitudes for S1 and S2 were measured at the Cz site, in 
the 50–70ms post-stimulus interval, using a computer algorithm based on previous 
studies (Olincy et al. 2010, Nagamoto et al. 1989): S2 P50 latency had to be a value 
within ± 10 ms of S1 P50 latency; P50 amplitude was measured relative to its preceding 
trough; S1 P50 waves with less than 0.5 μV were excluded. P50 ratio was calculated as 
S2/S1 P50. 
 
2.14 Time-frequency analyses methods 
 
Time-frequency analyses were performed using the 'wavelet method', based on Morlet 
wavelets with a 'width' of 4 (Roach and Mathalon, 2008; Başar et al. 2001). In each 
studied paradigm, power was extracted with a 1 Hz (frequency) and 1 msec (time) 
resolution, from single trials, using artefact-free data segments following the initial EEG 
processing routine described above. The time-frequency transformation was applied to 
the baseline and post-stimuli intervals. The EEG frequency bands of interest were Delta 
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(1-3Hz), Theta (4-7Hz), Alpha (8-12Hz), Beta (13-30Hz) and Gamma (31-100Hz). 
Power values were calculated in microV2, then for EROs calculation, relative baseline 
correction (the quotient of post stimuli power over baseline average power) was applied. 
Baseline lengths were determined separately for each band: Delta (-1000 to 0 ms), Theta 
(-250 to 0 ms), Alpha (-125 to 0 ms), Beta (-100 to 0 ms), Gamma (-50 to 0 ms). Hence, 
EROs presented in time-frequency spectrums in this thesis results chapters represent the 
relative change of spectral power in comparison to the baseline: 
Post stimuli power
Mean power in baseline interval
 . EROs of interest were considered to be those with a 
functional association, that is, linked to either: a) task (condition) effects; b) behavioural 
performance, as measured by oddball task reaction time; c) psychosis symptoms; or that 
would d) discriminate between patients and controls. To identify these EROs, t-test 
comparisons were performed between each paradigm's two stimuli EROs time-
frequency spectrums (target Vs non-target conditions, deviant Vs standard stimuli, S1 
Vs S2 clicks), between groups (controls Vs patients) and EROs time-frequency 
spectrums were regressed with reaction time and PANSS scores. This resulted in time-
frequency maps with clusters of statistically significant t-test scores and regression 
coefficients (Gross, 2014). These clusters were mapped onto target tone, deviant tone 
and S2/S1 EROs time-frequency spectrums, to delimitate EROs of interest. Task and 
reaction time effects on EROs were studied in patients and controls groups separately, 
to characterize disease effects, but also in the whole sample, the latter to maximize 
statistical power. The above method identifies specific EROs time-frequency clusters, 
where: a) the task effect is linked to either an attenuation or an increase in EROs 
between the two conditions; EROs have either a direct or an inverse relationship with b) 
processing speed (i.e., RT) and c) psychosis symptoms severity; d) patients show EROs 
deficits. Finally, composite EROs ratios combining EROs across frequencies were 
calculated, following the same rational as others have used in various studies 
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investigating EEG markers of attention and cognition (Schleiger et al. 2014, Sangal and 
Sangal 2014, Putman et al. 2014, Moretti et al. 2014, Staikou et al. 2012, Ogrim et al. 
2012, Leon-Carrion et al. 2009, Barry et al. 2009).  
EROs of interest, as defined above, were combined in composite EROs measures in 
order to reflect psychosis impairments in: 1) Isolated EROs time-frequency clusters; 2) 
EROs "collective behaviour", as ensembles of EROs time-frequency clusters that are 
functionally linked in each studied paradigm. This approach allows to establish 
functional links between different EROs, within and across the three studied paradigms 
and thus integrate different brain processes, as argued by various authors (Basar 2013, 
Buzsáki and Watson 2012, Moran and Hong 2011, Uhlhaas and Singer 2010). Although 
this overall method and rational was applied equally to the three studied paradigms, the 
specific time-frequency EROs clusters extracted from each and used in hypothesis 
testing are described in the respective results chapter (chapters 3 to 5). 
 
2.15 Statistical Analysis 
 
EROs time-frequency spectrums differences between conditions and groups, as well as 
the association between EROs and oddball task reaction time/psychosis symptoms, were 
analyzed and adjusted for multiple comparisons by means of a cluster based test statistic 
(for temporal and spectral adjacency) using a dependent/independent samples t-test or 
linear regression as appropriate and a threshold alpha=0.05; Monte Carlo significance 
probability was calculated using 1000 random partitions, the maximum of the cluster-
level summed t-values and a cluster threshold alpha=0.05 (Maris and Oostenveld, 
2007).  
Group differences for reaction time, extracted EROs, P300, MMN and P50 gating 
measures were tested by ANOVA models, including as covariates age, gender, lab and 
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smoking (smoker Vs non-smoker) status. An overall test of significance was followed 
up by multiple pairwise comparisons, correcting for experiment-wise error rate by 
means of the tukey-kramer test. Another ANOVA model with an interaction term: 
clinical group * (
Passive oddball EROs
Paired−click paradigm EROs
), as independent variable and oddball task 
EROs as dependent variable, was used to test the relationship between lower level and 
higher level EROs across the study groups. 
Passive oddball EROs
Paired−click paradigm EROs
 fraction increases 
in value when both salience and gating brain functions are stronger. The hypothesis 
here is that psychosis impairments in basic sensory processing (salience and gating 
mechanisms) converge and feed into higher-order cognitive (selective attention) 
impairment (Dias et al. 2011, Leitman et al. 2010, Gjini et al. 2010), in this way testing 
relationships between the studied paradigms EROs. The three paradigms EROs were 
introduced together in regression analysis to predict PANSS positive and negative 
symptoms scores. 
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CHAPTER THREE  
ODDBALL TASK EROS IN PSYCHOSIS 
3.0 Introduction 
 
In this chapter, abnormalities in the oddball task event-related measures are evaluated as 
to markers of genetic liability (and potential as psychosis endophenotypes) and also 
markers of psychosis chronicity. The sample recruitment, EEG data collection and 
statistical analysis methodologies which contributed to the following analyses are those 
outlined previously in chapter two. The following is examined in order to first identify 
relevant oddball task EROs and understand their dynamics: 1) the EROs condition 
effect, that is, the difference between oddball task target tone and non-target tone EROs 
responses, which should reveal EROs markers of selective attention resources allocation 
to stimulus processing. 2) the EROs association with reaction time, linking brain 
activity with a behavioural response that is indicative of brain processing speed. 3) the 
EROs association with psychosis symptoms as measured by PANSS total scores. 4) the 
EROs group effect, that is, controls Vs patients between-group comparisons of oddball 
task target and non-target tones EROs. EROs statistically associated to the above effects 
are considered relevant, thus extracted for hypothesis testing.  
As per the study aims, the main hypotheses here are that: psychosis patients show 
disease associated oddball task EROs deficits, when compared to controls; psychosis 
genetic liability will manifest as first-degree relatives’ intermediate deficits in oddball 
task EROs, between patients and healthy subjects; increasing oddball task EROs 
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deficits, starting from ARMS, through early psychosis patients to chronic psychosis 
patients will reflect disease progression. 
P300 ERP results, although not the main focus of attention in this study, are presented 
here because they are in themselves of interest, as per the large amount of published 
research on the P300 in psychosis, including by our group. Moreover, they help to 
validate and interpret overall findings. 
 
3.1 Between-group comparisons of P300 amplitude and reaction time 
Mean P300 ERP amplitude and latency, reaction time (RT) by clinical group and the 
results of the ANOVA P300 amplitude group comparisons are shown in Tables 3.1a and 
3.1b. There was no significant effect of group on P300 amplitude, after adjustment for a 
significant gender effect, F(1,252) = 7.25, p=0.008, where women showed larger P300 
amplitude than men (∆ = 1.81µV, 95% CI= 0.49 to 3.13µV). Age, smoking and lab had 
no effect on P300 amplitude. P300 latency increased with age, F(1,252) = 43.22, 
p=2.85e-10, β=0.87, but there were no significant group, lab, smoking, nor gender 
effects. Estimated mean reaction time (RT) by clinical group is shown in Table 3.1a and 
Figure 3.1b. RT showed a significant main effect for group (F(4,260) = 6.83, p<0.0001), 
where controls showed faster RT than early psychosis patients (∆ = -117ms, 95% CI = -
182 to -52ms) and chronic psychosis patients (∆ = -68ms, 95% CI = -129 to -7ms). All 
other group comparisons showed no statistically significant difference in RT. There was 
a gender main effect on RT (F(1,260) = 12.24, p<0.001), men were on average faster 
than women  (∆ = -49ms, 95% CI= -78 to -19ms). There was a significant group * age 
interaction effect, F(1,236) = 5.21, p<0.001, where RT was slower with advancing age 
in chronic patients (β=3.58, p=0.03), but faster with advancing age in early psychosis 
(β=-11.98, p=0.01) and ARMS (β=-13.22, p=0.01) subjects. There was no significant 
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3.2 Oddball task EROs time-frequency plots 
 
Oddball task paradigm EROs time-frequency plots for both target and non-target tone, 
by study group, are displayed in Figure 3.2. 
 
Oddball task EROs time-frequency plots by condition and study group 
 
Figure 3.2 The EROs time-frequency plots depict mean change in power, in relation to the prestimulus baseline, for 
target (left) and non-target (right) tones and for each study group (different rows). EEG frequency is indicated on the 
y-axis of each plot and spans 0 to 100Hz. Time is indicated on the x-axis and spans 0 to 1000ms. EPP - early 
psychosis patients; CPP - chronic psychosis patients; ARMS - 'At risk mental state' subjects. 
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3.3 Oddball task EROs condition effects 
 
Oddball task EROs condition effects in the overall sample (controls, patients, first-
degree relatives and ARMS groups combined) are shown in Figure 3.3a. In the studied 
time-frequency spectrum, target tones elicited larger EROs than non-target tones 
(positive t-test scores) in the delta/theta frequency range, with maximum difference 
between approx. 200-400ms post stimulus and in the gamma range, from approx. 500 
ms post stimulus; target tones elicited smaller EROs (negative t-test scores) than non-
target tones in the alpha/beta frequency range, from approx. 350ms poststimulus and in 
the gamma range around 200ms poststimulus. When examined separately (Figures 3.3b 
and 3.3c), the oddball task EROs condition effect shows a similar cluster pattern 
between patients and controls, except for the late gamma positive cluster, where patients 
lacked discrimination between target and non-target tones. 
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Figure 3.3 T-test comparisons between target Vs non-target tones EROs for a) all subjects combined, b) controls 
and c) patients groups. EEG frequency is indicated on the y-axis of each plot and spans 0 to 100Hz. Time is 
indicated on the x-axis and spans 0 to 1000ms. T-test scores are indicated on a colour scale located to the far 
right of each plot. All results are adjusted for multiple comparisons and a mask (white coulour) applied for non 
significant comparisons, using a significance threshold of p<.05. 
 
3.4 Oddball task EROs relationships with reaction time 
 
The association between oddball task target tone EROs and reaction time in the overall 
sample (controls, patients, fisrt-degee relatives and ARMS combined) is shown in 
Figure 3.4a. Three clusters of linear regression coefficients representing significant 
associations between target tone EROs and reaction time can be observed. The clusters 
alternate between negative and positive signals: positive coefficients reflect a direct 
relationship between EROs and reaction time (the larger EROs, the slower reaction 
time), whereas negative coefficients represent an inverse relationship (the larger EROs, 
the faster reaction time). The first cluster is negative and composed of early gamma 
followed by delta/theta EROs, the second cluster is positive and composed by "mid 
latency" gamma followed by beta/alpha EROs, the third cluster is negative and 
composed by late gamma/beta EROs. When examined separately and compared 
(Figures 3.4b and 3.4c), patients differed from controls in lacking the third cluster. 













Figure 3.4 Linear regression association between oddball task target tone EROs and reaction time for a) all subjects 
combined, b) controls and c) patients groups. EEG frequency is indicated on the y-axis and spans 0 to 100Hz; time is 
indicated on the x-axis and spans 0 to 1000ms; linear regression coefficients results are indicated on a colour scale 
located to the far right of each plot. Results are adjusted for multiple comparisons and then a mask (white colour) 
applied for non significant comparisons, using a significance threshold of p<.05. Negative coefficients are 
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3.5 Oddball task EROs relationships with psychosis symptoms 
 
The association between oddball task target tone EROs and PANSS total symptoms 
score in the patients sample (early psychosis patients and chronic psychosis patients 
combined) is displayed in Figure 3.5.  
The overall pattern of association is similar to that between oddball task target tone 
EROs and reaction time, with the three regression coefficients clusters described above. 
There is a negative (inverse) association between the severity of psychosis symptoms as 
measured by PANSS total score and patients' target tone delta/theta EROs; a positive 
association with "mid latency" gamma followed by beta/alpha EROs; and again a 
negative association with late gamma/beta EROs. A similar pattern of associations was 
observed between the target tone EROs and PANSS positive and negative psychosis 
symptoms scores, when examined separately (not shown).  
 
Oddball task target tone EROs and PANSS total score 
 
Figure 3.5 Linear regression association between target tone EROs and PANSS total score. EEG 
frequency is indicated on the y-axis and spans 0 to 100Hz; time is indicated on the x-axis and spans 0 to 
1000ms; linear regression coefficients are indicated on a colour scale located to the far right of each 
plot. Results are adjusted for multiple comparisons and then a mask (white colour) applied for non 
significant comparisons, using a significance threshold of p<.05. Negative coefficients are represented 
by "cold" colours whereas positive coefficients are represented by "hot" colours. 
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3.6 Controls Vs patients’ oddball task EROs  
 
The comparison between controls and patients (early psychosis patients and chronic 
psychosis patients combined) oddball task two tones EROs are displayed in Figure 3.6. 
T-test scores show reduced delta/theta EROs in patients compared to controls, both for 
target and for non-target tones, with the largest t-test scores between approx. 200-400ms 
post stimulus.  
 
Controls Vs Psychosis patients oddball task EROs 





Figure 3.6 T-test scores (colour scale located to the far right of the plot) for comparisons between controls Vs 
patients a) oddball task target tone EROs and b) oddball task non-target tone EROs. EEG frequency is indicated on 
the y-axis and spans 0 to 100Hz; time is indicated on the x-axis and spans 0 to 1000ms; t-test scores are indicated on 
a colour scale located to the far right of each plot. Results are adjusted for multiple comparisons and then a mask 
(white colour) applied for non significant comparisons, using a significance threshold of p<.05. "Hot" colours 
represent larger EROs in controls. 
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3.7 Between-group comparisons of oddball task composite EROs  
 
Relevant oddball task EROs were extracted from the oddball task target tone time-
frequency spectrum, based on the observation of the above effects, as indicated in figure 
3.7a: 1) a ratio was calculated between target tone EROs measured within the negative 
clusters and the positive cluster boundaries that were defined by target tone EROs 
regression with reaction time (Figure 3.4a), taking the maximum EROs value from each 
cluster. This aims to reflect psychosis related abnormal dynamics between EROs 
clusters that are functionally linked. 2) that ratio was multiplied by the maximum target 
tone EROs within the boundaries of the delta/theta cluster defined by target tone 
between-group comparisons (Figure 3.6a). This aims to reflect a psychosis related 
deficit in the isolated delta/theta EROs cluster.   
Extraction of oddball task EROs from target tone time-frequency spectrum 
    
  
  Oddball task composite EROs = 
𝐴∗𝐶
𝐵
 * 𝐷 
Figure 3.7a The time-frequency boundaries of beta coefficients and t-test clusters scores identified in Figures 3.4a 
and 3.6a were mapped onto the target tone time-frequency spectrum, extracting four EROs clusters (A, B, C and D), 
used to calculate oddball task composite EROs. EROs from cluster B are in the fraction denominator because they 
have an inverse relationship with RT when compared to EROs from cluster A, C and D. 




Mean oddball task composite EROs for all the study groups are displayed in Table 3.7a. 
ANOVA between-group comparisons results are displayed in Table 3.7b. There was a 
significant main group effect: chronic psychosis patients had smaller oddball task 
composite EROs than controls, ARMS and first-degree relatives; early psychosis 
patients had smaller oddball task composite EROs than controls, but not first-degree 
relatives, nor ARMS subjects; there were no significant differences between controls, 
ARMS and first-degree relatives groups. There were no significant age, gender, 
smoking, nor lab main effects.  
Oddball task composite EROs 
 
 
Figure 3.7b: Mean oddball task composite EROs (log 






Table 3.7a | Odball task composite 
EROs group means 
Controls EPP   
9.79 (0.70) 6.54 (1.04)  
CPP  ARMS  Relatives 
6.28 (0.93) 8.63 (0.99) 8.78 (0.74) 
 
 
Table 3.7b | Oddball task composite EROs between-group comparisons 
Group comparisons Est. Mean Difference 95% CI F  (p value) 






2. Controls Vs CPP 0.52 0.17 to 0.87 
3. Controls Vs ARMS 0.08 -0.28 to 0.45 
4. Controls Vs Relatives 0.16 -0.15 to 0.46 
5. EPP Vs CPP  0.09 -0.33 to 0.51 
6. EPP Vs ARMS -0.35 -0.78 to 0.08 
7. EPP Vs Relatives -0.28 -0.66 to 0.11 
8. CPP Vs ARMS -0.44 -0.85 to -0.03 
9. CPP Vs Relatives -0.36 -0.72 to -0.004 
10. ARMS Vs Relatives -0.07 -0.30 to 0.44 
Oddball task composite EROs (log transformed) mean differences between the study groups and 95% confidence 
intervals, adjusted for multiple comparions. EROs values were log transformed to reduce the skewness of data 
before ANOVA comparisons. EPP - early psychosis patients; CPP - chronic psychosis patients; ARMS - 'At risk 
mental state' subjects. 
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3.8 Oddball task composite EROs and psychosis symptoms 
 
There were no significant associations between PANSS scores in psychosis patients and 
oddball task composite EROs. 
 
3.9 Oddball task composite EROs deficits - genetic Vs chronicity 
effects 
 
Results in this chapter show that oddball task composite EROs, which reflect selective 
attention resource allocation to target tone stimuli processing, were reduced in chronic 
and early psychosis patients, compared to controls. These EROs were significantly 
smaller in chronic psychosis patients, but not in early psychosis patients, when 
compared to the ARMS and first-degree relatives groups. Moreover, ARMs and first-
degree relatives groups were not statistically significantly different from either early 
psychosis patients or controls and had intermediate mean values between the latter 
groups. This, on the whole, suggests that oddball task composite EROs are impaired by 
psychosis disease progression and also influenced by genetic liability. This is further 
discussed in Chapter 7.  




PASSIVE ODDBALL PARADIGM EROS IN 
PSYCHOSIS 
4.0 Introduction 
In this chapter, results are presented in the same structure as of chapter three. 
Abnormalities in passive oddball paradigm event-related oscillations (EROs) are 
evaluated as to their influence by genetic liability (as potential endophenotypes for 
psychosis) and psychosis chronicity. The differences between deviant tone and standard 
tone EROS responses, that is, condition effects, are examined in order to reveal EROs 
markers of stimulus salience. The functional role of passive oddball paradigm EROs is 
further examined by looking at their association with oddball task reaction time (RT), 
linking passive oddball paradigm EROs to a behavioural response, which is indicative 
of brain processing speed and attention-related. Passive oddball paradigm EROs 
possible role in the physiopathology of psychosis symptoms is studied by testing the 
associations between EROs and PANSS symptoms scores. The effect of psychosis 
disease on passive oddball paradigm EROs is assessed by comparing controls Vs 
psychosis patients’ deviant and standard tone EROs. After examining those effects, 
relevant EROs are extracted and compared between all the study groups. The hypothesis 
here are that: psychosis genetic liability will manifest as reduced EROs in first-degree 
relatives, compared to healthy subjects and illness chronicity will produce a gradient in 
passive oddball paradigm EROs: ARMS>early psychosis patients>chronic psychosis 
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patients. MMN ERP results, although not the main focus of attention in this study, are 
presented here. 
 
4.1 Between-group comparisons of MMN  
 
Mean MMN amplitude by clinical group and the results of ANOVA between-group 
comparisons are shown in table 4.1: there was a significant group main effect, where 
early psychosis patients showed significantly smaller MMN amplitude than all other 
groups; there were no statistically significant differences between controls, first-degree 
relatives, ARMS or chronic psychosis patients groups. MMN decreased with age in the 
overall sample, F(1,246)=8.33, p=0.004, β=1.72. Women had larger MMN than men, 
F(1,246)=7.56, ∆=-1.05µV, 95% CI= -1.79 to -0.30µV, p=0.006. Smoking and testing 
lab had no main effects on MMN. 
 
MMN 
MMN waveforms (Fz) 
 
Figure 4.1a MMN grand average waveforms for all study 
groups. Amplitude (microV) is plotted over time (seconds). 
Time zero denotes the occurrence of stimuli. Waveforms have 
been smoothed and the peak of the grand average waveforms 
does not coincide with the mean of the individual MMN peak 





Table 4.1a | MMN amplitude means 
Controls EPP  
-3.46 (0.33) -1.60 (0.57)  
CPP  ARMS Relatives 
-3.96 (0.44)  -4.24 (0.59) -4.11 (0.40) 
Mean (standard error) MMN amplitude in µV 
at Fz electrode, for each study group, adjusted 































Table 4.1b | MMN amplitude between-group comparisons 
Group comparisons Est. Mean  
Difference 
95% CI F (df) 
p value 




3.57 (4,246) p=0.008  
2. Controls Vs CPP 0.50 -1.03 to 2.03 
3. Controls Vs ARMS 0.78 -1.07 to 2.62 
4. Controls Vs Relatives 0.65 -0.85 to 2.14 
5. EPP Vs CPP  2.36 0.36 to 4.36 
6. EPP Vs ARMS 2.63 0.40 to 4.87 
7. EPP Vs Relatives 2.51 0.38 to 4.63 
8. CPP Vs ARMS 0.27 -1.80 to 2.36 
9. CPP Vs Relatives 0.15 -1.42 to 1.71 
10. ARMS Vs Relatives -0.13 -2.19 to 1.93 
MMN amplitude estimated mean differences between the study groups and 95% confidence intervals, 
adjusted for multiple comparisons. EPP - early psychosis patients; CPP - chronic psychosis patients; ARMS - 






Chapter five - Sensory gating paradigm EROs in psychosis 
64 
 
4.2 Passive oddball paradigm EROs time-frequency plots 
 
Passive oddball paradigm EROs time-frequency plots for both deviant and standard 
tone, by study group, are displayed in Figure 4.2. 
 
Passive oddball EROs time-frequency plots  
 
Figure 4.2 The EROs time-frequency plots depict mean change in power, in relation to the prestimulus baseline, for 
passive oddball paradigm deviant (left) and standard (right) tones and for each study group (different rows). EEG 
frequency is indicated on the y-axis of each plot and spans 0 to 100Hz. Time is indicated on the x-axis and spans 0 to 
300ms. EPP - early psychosis patients; CPP - chronic psychosis patients; ARMS - 'At risk mental state' subjects. 
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4.3 Passive oddball paradigm EROs condition effects 
 









Figure 4.3 T-test scores for comparisons between passive oddball paradigm deviant Vs standard tone EROs for a) all 
subjects combined, b) controls and c) psychosis patients. EEG frequency is indicated on the y-axis of each plot and 
spans 0 to 100Hz. Time is indicated on the x-axis and spans 0 to 300ms. T-test scores are indicated on a colour scale 
located to the far right of each plot. All results are adjusted for multiple comparisons and a mask (white coulour) 
applied for non significant comparisons, using a significance threshold of p<.05. 
 
 
Passive oddball paradigm EROs condition (deviant Vs standard tones) effects in the 
overall study sample (controls, patients, first-degree relatives and ARMS combined) are 
shown in figure 4.3. Deviant tones elicited larger early (up to approx. 40ms post 
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stimulus) gamma EROs and larger delta/theta EROs than standard tones throughout the 
studied time interval, with maximum t-test values approx. between 50-150ms; deviant 
tones elicited less beta EROs than standard tones (from approx. 175ms post stimulus). 
When examining EROs condition effects separately in controls and patients groups, 
only the delta/theta EROs cluster is present in controls and no difference between the 
two tone types is observed in psychosis patients. 
 
4.4 Passive oddball paradigm EROs relationships with oddball task 
reaction time  
 
The associations between deviant tone EROs / the difference deviant-standard tone 
EROs and oddball task reaction time (RT) in the overall study sample (controls, 
patients, first-degree relatives and ARMS combined) are shown in Figure 4.4a and 4.4b 
respectively. In Figure 4.4a, two clusters of linear regression coefficients representing 
significant associations between deviant tone EROs and RT can be observed. The 1st 
cluster and 2nd cluster have respectively negative and positive coefficients: negative 
coefficients reflect an inverse relationship (the larger EROs, the faster RT), whereas 
positive coefficients represent a direct relationship between EROs and RT (the larger 
EROs, the slower RT). The first cluster is composed of early gamma EROs and 
delta/theta EROs, the second is composed by gamma/beta EROs. When the patterns of 
associations between deviant tone EROs and RT were examined separately for patients 
and controls (not shown), they did not differ from the above. In Figure 4.4b, significant 
clusters overlap with the previously described clusters in Figure 4.4a, but more 
circumscribed in the time-frequency spectrum. 
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Passive oddball paradigm EROs and oddball task reaction time 
All subjects 





Figure 4.4 Linear regression association between a) deviant tone EROs and oddball task reaction time (RT), b) 
deviant-standard tone EROs and RT. EEG frequency is indicated on the y-axis and spans 0 to 100Hz; time is indicated 
on the x-axis and spans 0 to 300ms; linear regression coefficients are indicated on a colour scale located to the far 
right of each plot. Results are adjusted for multiple comparisons and then a mask (white colour) applied for non 
significant comparisons, using a significance threshold of p<.05. Negative coefficients are represented by "cold" 
colours whereas positive coefficients are represented by "hot" colours. 
 
4.5 Passive oddball EROs relationships with psychosis symptoms 
 
The associations between deviant tone EROs / the difference deviant-standard tone 
EROs and PANSS total symptoms score in the patients sample (early psychosis patients 
and chronic psychosis patients combined) is displayed in figure 4.5.  
The pattern of associations partially overlaps with that between passive oddball EROs 
and oddball task reaction time described in 4.5. There is a negative (inverse) association 
between the severity of psychosis symptoms as measured by PANSS total scores and 
patients' deviant tone early gamma EROs; a positive association with deviant tone late 
gamma/beta EROs; a positive association with deviant-standard tone late beta EROs. A 
similar pattern of clusters was observed when PANSS positive and negative symptoms 
scores were used in place of PANSS total scores (not shown).  
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Passive oddball paradigm EROs and PANSS total score 





Figure 4.5 Linear regression association between a) deviant tone EROs and PANSS total score, b) deviant-standard 
tones EROs difference and PANSS total score. EEG frequency is indicated on the y-axis and spans 0 to 100Hz; time 
is indicated on the x-axis and spans 0 to 300ms; linear regression coefficients are indicated on a colour scale located 
to the far right of each plot. Results are adjusted for multiple comparisons and then a mask (white colour) applied for 
non significant comparisons, using a significance threshold of p<.05. Negative coefficients are represented by "cold" 
colours whereas positive coefficients are represented by "hot" colours. 
 
4.6 Controls Vs patients’ passive oddball paradigm EROs 
 
There were no significant differences between controls' and patients' deviant tone, 
standard tone or deviant-standard tone EROs. 
 
4.7 Between-group comparisons of passive oddball paradigm 
composite EROs 
 
Relevant passive oddball paradigm composite EROs were extracted based on the 
observation of the above effects, indicated in Figure 4.7a.  
The ratio was calculated between EROs within the gamma and theta positive clusters 
boundaries and EROs within the beta negative cluster boundaries, defined by the 
passive oddball paradigm EROs condition effects (Figure 4.7a), taking the maximum 
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EROs value from each cluster. This aims to reflect psychosis related abnormal 
dynamics between EROs clusters that are functionally linked. Unlike in oddball task 
EROs extraction, this ratio was not weighed to reflect deviant tone EROs patients Vs 
controls groups differences, given these were statistically non significant.   
 








Figure 4.7a The time-frequency boundaries of t-test clusters scores identified in Figure 4.3a were mapped onto 
the deviant tone time-frequency spectrum, extracting three EROs clusters (A, B and C), used in the fraction above 
to calculate passive oddball paradigm composite EROs. EROs from cluster C are in the fraction denominator 
because they show an inverse condition effect compared to EROs from clusters A and B. 
 
Mean passive oddball paradigm composite EROs for all the study groups are displayed 
Table 4.7a. ANOVA between-group comparisons results are displayed in Table 4.7b 
and show a significant main effect for group: there was a trend for larger passive 
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oddball paradigm composite EROs in controls, compared to early psychosis patients; 
first-degree relatives showed a larger ratio than controls, early psychosis patients and 
ARMS subjects, but no significant difference to chronic psychosis patients; early 
psychosis patients showed a smaller ratio than chronic psychosis patients but no 
significant difference to ARMS subjects. There was a significant age effect, 
F(1,246)=9.35, p=0.002, where passive oddball paradigm composite EROs decreased 
with age (β=-0.16). Gender, smoking and lab had no statistically significant effect on 
passive oddball paradigm composite EROs. 
 
Passive oddball paradigm composite EROs 
 
Figure 4.7b: Mean passive oddball paradigm composite EROs 
(log transformed) and 95% confidence intervals for the study 




Table 4.7a | Passive oddball paradigm 
composite EROs group means 
Controls EPP   
0.99 (0.03) 0.85 (0.05)  
CPP  ARMS  Relatives 
1.04 (0.04) 0.93 (0.06) 1.15 (0.04) 
Mean (se) passive oddball paradigm 
composite EROs for the study groups, 
adjusted for age.  
Table 4.7b | Passive oddball paradigm composite EROs between-group comparisons 
Group comparisons Est. Mean Difference 95% CI F (df)  
p value 






2. Controls Vs CPP -0.04 -0.17 to 0.09 
3. Controls Vs ARMS 0.05 -0.11 to 0.20 
4. Controls Vs Relatives -0.13 -0.26 to -0.004 
5. EPP Vs CPP  -0.18 -0.34 to -0.008 
6. EPP Vs ARMS -0.09 -0.26 to 0.08 
7. EPP Vs Relatives -0.27 -0.44 to -0.10 
8. CPP Vs ARMS -0.09 -0.09 to 0.27 
9. CPP Vs Relatives -0.10 -0.23 to 0.04 
10. ARMS Vs Relatives -0.18 -0.18 to -0.00005 
Passive oddball paradigm composite EROs (log transformed) mean differences between the study groups and 95% 
confidence intervals. adjusted for multiple comparions. EROs values were log transformed to reduce the skewness 
of data before ANOVA comparisons. EPP - early psychosis patients; CPP - chronic psychosis patients; ARMS - 'At 
risk mental state' subjects. 
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4.8 Passive oddball paradigm composite EROs and psychosis 
symptoms 
 
There was a significant association between passive oddball paradigm composite EROs 
and PANSS negative symptoms scores in chronic psychosis patients (Figure 4.8, R2 
linear=0.21, r= 0.46, p<0.01), but not in early psychosis patients. In chronic patients, the 
larger passive oddball paradigm composite EROs, the less severe psychosis negative 
symptoms. 
 
Passive oddball paradigm composite EROs and psychosis symptoms in chronic 
psychosis 
 
Figure 4.8 Scatter plot and fitted regression line showing the relationship between passive oddball paradigm 
composite EROs and PANSS negative symptoms scores, in the chronic psychosis patients sample. EROs and 
PANSS scores have been log transformed. 
 
  
Chapter five - Sensory gating paradigm EROs in psychosis 
72 
 
4.9 Passive oddball paradigm composite EROs abnormalities - genetic 
Vs chronicity effects 
 
Larger passive oddball paradigm composite EROs correspond to larger deviant tone 
EROs modulation in the time-frequency regions of interest, indicating stronger stimulus 
salience attribution and resulting in faster RT. Results in the chapter show that, after 
adjustment for age, passive oddball paradigm composite EROs were overly large in 
first-degree relatives, compared to controls, indicating a psychosis associated genetic 
influence on those EROs. The fact that genetically liable but disease-free and 
assymptomatic subjects had increased passive oddball paradigm composite EROs 
compared to controls, suggests this may be a compensatory mechanism. Chronic 
psychosis patients show larger passive oddball paradigm composite EROs than early 
psychosis patients, which means that psychosis patients are able, over time and as they 
get distanced from disease onset, to enhance this brain function. Moreover, in the 
chronic patients group, having larger passive oddball paradigm composite EROs was 
linked to showing less psychosis symptoms. Passive oddball paradigm composite EROs 
are therefore influenced by both psychosis genetic liability and disease progression. 
This is further discussed in Chapter 7.   
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CHAPTER FIVE  
PAIRED-CLICK PARADIGM EROS IN 
PSYCHOSIS 
5.0 Introduction 
In this chapter, results are presented in a similar structure as in chapters three and four. 
Abnormalities in paired-click paradigm EROs are evaluated as to their influence by 
genetic liability and psychosis disease chronicity. The dynamics of paired-click 
paradigm EROs in evaluated by examining condition effects, that is, the differences 
between S1 (conditioning) tone and S2 (test) tone EROs, which should reveal 
neurophysiological markers of brain sensory gating mechanisms. The functional role of 
paired-click paradigm EROs is further examined by looking at their association with 
oddball task reaction time, linking sensory gating brain mechanisms with a behavioural 
response that is indicative of brain processing speed and attention-related. The 
relationships between paired-click paradigm EROs and psychosis symptoms are studied 
by testing their associations with PANSS scores. The effect of psychosis disease on 
paired-click paradigm EROs is assessed by comparing controls Vs psychosis patients 
S1, S2 and S2/S1 EROs. After examining the above effects, relevant EROs are extracted 
and compared between all the study groups. The hypothesis here are that: psychosis 
genetic liability will manifest as reduced paired-click paradigm EROs in first-degree 
relatives, compared to healthy subjects and that illness chronicity will produce a 
gradient in paired-click paradigm EROs: ARMS<early psychosis patients<chronic 
psychosis patients. P50 ERP ratio results, although not the main focus of attention in 
this study, are presented here. 
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5.1 Between-group comparisons of P50 ratio 
 
Mean P50 ratio by clinical group and the results of the ANOVA group comparisons are 
shown in table 5.1: there was a significant group main effect, where chronic psychosis 
patients had larger P50 ratio than controls and first-degree relatives groups; and there 
were no statistically significant differences between the controls, early psychosis 
patients, first-degree relatives, or ARMS groups. P50 ratio increased (meaning 
worsening gating) with age in the overall sample, F(1,218)=6.69, p=0.01, β=0.007. No 
significant main effects for gender, smoking or lab were found. 
P50 ratio 
P50/N100 waveforms (Cz)  
 
Table 5.1a | P50 ratio means 
Controls EPP   
0.51 (0.06) 0.72 (0.10)  
CPP  ARMS Relatives 
0.90 (0.08) 0.65 (0.11) 0.46 (0.07) 
Mean (standard error) P50 ratios (S2 P50 
amplitude/S1 P50 amplitude) at Cz electrode, for the 
study groups. The P50 ratio is adjusted for age.  
 
 
Figure 5.1 P50 grand average ERP waveforms for 
the overall study sample. Amplitude (microV) is 
plotted over time (seconds). Waveforms have been 
smoothed with a 10ms time window.  
 
 Table 5.1b | P50 ratio between-group comparisons 
Group comparisons Est. Mean Difference 95% CI F (df)  
p value 






2. Controls Vs CPP -0,39 -0,68 to -0.10 
3. Controls Vs ARMS -0,14 -0,47 to 0.19 
4. Controls Vs Relatives 0,05 -0,22 to 0.32 
5. EPP Vs CPP  -0,19 -0,55 to 0.17 
6. EPP Vs ARMS 0,06 -0,31 to 0.44 
7. EPP Vs Relatives 0,26 -0,11 to 0.62 
8. CPP Vs ARMS 0,25 -0,12 to 0.62 
9. CPP Vs Relatives 0,44 0,15 to 0.74 
10. ARMS Vs Relatives 0,19 -0,18 to 0.56 
P50 ratio estimated mean differences between the study groups and 95% confidence intervals, adjusted for 
multiple comparisons. EPP - early psychosis patients; CPP - chronic psychosis patients; ARMS - 'At risk mental 
state' subjects. 
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5.2 Paired-click paradigm EROs time-frequency plots 
 
Paired-click paradigm S2/S1 tone EROs time-frequency plots, by study group, are 
displayed in Figure 5.2. 
 
Paired-click paradigm S2/S1 tone ERO time-frequency plots  
 
Figure 5.2 The time-frequency plots depict S2/S1 tone EROs, for each study group (different rows). EEG 
frequency is indicated on the y-axis of each plot and spans 0 to 100Hz. Time is indicated on the x-axis and spans 0 
to 300ms. EPP - early psychosis patients; CPP - chronic psychosis patients; ARMS - 'At risk mental state' 
subjects. 
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5.3 Paired-click paradigm EROs condition effects 
 
Paired-click paradigm EROs condition effects in the overall sample (controls, patients, 
first-degree relatives and ARMS groups combined) are shown in figure 5.3.  
 









Figure 5.3 t-test scores for comparisons between S1 Vs S2 tones EROs are presented for a) all subjects 
combined, b) controls and c) patients. EEG frequency is indicated on the y-axis of each plot and spans 0 to 
100Hz. Time is indicated on the x-axis and spans 0 to 200ms. T-test scores are indicated on a colour scale 
located to the far right of each plot. All results are adjusted for multiple comparisons and a mask (white coulour) 
applied for non significant comparisons, using a significance threshold of p<.05. 
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S1 tones elicit larger delta/theta EROs than S2 tones, with decreasing t-test values along 
the studied interval time axis. S1 tones elicit smaller gamma EROs than S2 tones 
between approx. 50-100ms post stimulus. The gamma EROs condition effect is not 
observed when examining patients responses separately. 
 
 
5.4 Paired-click paradigm EROs relationships with oddball task 
reaction time 
 
The association between S1 EROs, S2 EROs, S2/S1 EROs ratio and oddball task 
reaction time (RT) in the overall sample (controls, patients, first-degree relatives and 
ARMS groups combined) are shown in figure 5.4.  
Three clusters of linear regression coefficients representing significant associations 
between S2/S1 EROs ratio and oddball task RT can be observed. Two clusters have 
negative signals and one has positive signal: positive coefficients reflect a direct 
relationship between sensory EROs ratio and RT (the larger the ratio, or the worse 
sensory EROs gating is, the slower RT); negative coefficients represent an inverse 
relationship (the opposite relationship between sensory EROs ratio and RT). The two 
negative clusters are composed first of early gamma, followed by gamma/beta EROs. 
The gamma EROs cluster is between approx 50-100ms post stimulus, between the P50 
and N100 ERP peaks. The positive cluster is composed by delta/theta EROs and spans 
the studied time interval (0-200ms).  
The associations between S1 EROs and RT form similar clusters to the ones described 
above, except with opposite signals and one can observe the delta/theta cluster 
"extending" earlier in time to gamma frequencies.  
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The associations between S2 EROs and RT form two clusters. The positive cluster is 
composed of delta/theta EROs and the negative cluster is composed of early gamma 
EROs followed by later beta/alpha EROs. 
 
Paired-click paradigm EROs and oddball task reaction time (RT)   
 
a) S2/S1 EROs ratio and oddball task RT 
 
  
b) S1 EROs and oddball task RT 
 
c) S2 EROs and oddball task RT 
 
Figure 5.4 Linear regression associations between oddball task reaction time and paired-click paradigm a) 
S2/S1 EROs ratio, b) S1 and c) S2 EROs. All subjects were included in this analyses (controls, first-degree 
relatives, patients and ARMS groups combined). EEG frequency is indicated on the y-axis and spans 0 to 
100Hz; time is indicated on the x-axis and spans 0 to 200ms; linear regression coefficients are indicated on a 
colour scale located to the far right of each plot. Results are adjusted for multiple comparisons and then a mask 
(white colour) applied for non significant comparisons, using a significance threshold of p<.05. Negative 
coefficients are represented by "cold" colours whereas positive coefficients are represented by "hot" colours. 
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5.5 Paired-click paradigm EROs relationships with psychosis 
symptoms 
 
The association between paired-click paradigm EROs and PANSS total symptoms score 
in the patients sample (early psychosis patients and chronic psychosis patients 
combined) is displayed in figure 5.5.  
Paired-click paradigm EROs and PANSS total score 
a) S2/S1 EROs ratio and PANSS total score 
 
  
b) S1 EROs and PANSS total score 
 
c) S2 EROs and PANSS total score 
 
Figure 5.5 Linear regression associations between PANSS total scores and a) S2/S1 EROs ratio, b) S1 and c) S2 
EROs. All patients for whom EEG and symptoms data were available were included in this analyses (early psychosis 
and chronic psychosis patients combined). EEG frequency is indicated on the y-axis and spans 0 to 100Hz; time is 
indicated on the x-axis and spans 0 to 200ms; linear regression coefficients are indicated on a colour scale located to 
the far right of each plot. Results are adjusted for multiple comparisons and then a mask (white colour) applied for non 
significant comparisons, using a significance threshold of p<.05. Negative coefficients are represented by "cold" 
colours whereas positive coefficients are represented by "hot" colours. 
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The overall pattern of association is similar to that between S2/S1 EROs ratio and RT, 
with the regression coefficients clusters described above, but more circunscribed in their 
time-frequency boundaries. The gamma cluster is absent from the S2/S1 EROs ratio 
association with psychosis symptoms. 
 
5.6 Controls Vs patients paired-click paradigm EROs 
 
The comparisons between controls and patients (early psychosis patients and chronic 
psychosis patients combined) paired-click paradigm EROs time-frequency spectrums 
are displayed in figure 5.6.  
T-test scores show increased S2/S1 theta EROs ratio in patients, compared to controls, 
across the studied time interval. Controls show larger EROs than patients for both S1 
and S2 conditions, in an early time window centered on alpha/lower beta range 
oscillations. 
 
Paired-click paradigm EROs - Controls Vs Patients 
 
a) S2/S1 EROs ratio 
 





b) S1 EROs 
 
c) S2 EROs 
 
Figure 5.6 T-test scores (colour scale located to the far right of the plot) for comparisons between controls Vs 
patients a) S2/S1 EROs ratio, b) S1 tone EROs and c) S2 tone EROs. EEG frequency is indicated on the y-axis 
and spans 0 to 100Hz; time is indicated on the x-axis and spans 0 to 200ms; results are adjusted for multiple 
comparisons and then a mask (white colour) applied for non significant comparisons, using a significance 
threshold of p<.05. 
 
 
5.7 Between-group comparisons of paired-click paradigm composite 
EROs 
 
Relevant paired-click paradigm EROS were extracted from S2/S1 tone time-frequency 
spectrum, based on the observation of the above effects, as indicated in Figure 5.7a:  
1) S2/S1 EROs time-frequency spectrum was computed; 
2) from S2/S1 EROs, the ratio between values within the time-frequency boundaries of 
the positive theta cluster and the negative gamma/beta clusters associated with oddball 
task reaction time (Figure 5.4a) was calculated, taking the maximum EROs value from 
each cluster. This aims to reflect psychosis related abnormal dynamics between paired-
click paradigm EROs clusters that are functionally linked.   
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3) this ratio was finally multiplied by the minimum S2/S1 EROs value within the 
boundaries of the negative theta cluster from group comparisons (Figure 5.6a). This 
aims to reflect a psychosis related gating deficit in the isolated delta/theta cluster. 
 







Paired-click paradigm composite EROs = 
𝐴
𝐵∗𝐶
 * 𝐷 
The time-frequency boundaries of beta coefficients and t-test clusters scores identified in Figures 5.4a and 5.6a were 
mapped onto S2/S1 EROs time-frequency spectrum, extracting four EROs clusters (A, B, C and D), used to calculate 
paired-click paradigm composite EROs. EROs from cluster B and C are in the fraction denominator because they 
have an inverse relationship with RT when compared to EROs from cluster A and D. 
 
   
Mean paired-click paradigm composite EROs for all the study groups are displayed in 
Table 5.7a. ANOVA between-group comparisons results are displayed in Table 5.7b 
and show a significant main effect for group: controls showed smaller paired-click 
paradigm composite EROs than early and chronic psychosis patients. ARMS subjects 
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showed smaller values than early psychosis patients, chronic psychosis patients and 
first-degree relatives. The latter group did not differ from controls nor patients and 
showed a mean intermediate value between them. Age, gender, smoking and lab had no 
statistically significant effect on paired-click paradigm composite EROs. 
 






Table 5.7a | Paired-click paradigm 
composite EROs group means 
Controls EPP   
0.28 (0.03) 0.42 (0.04)  
CPP  ARMS  Relatives 
0.45 (0.04) 0.22 (0.04) 0.38 (0.03) 
Figure 5.7b Mean paired-click paradigm composite EROs (log 
transformed) and 95% confidence intervals for the study 
groups. 
 
Table 5.7b | Paired-click paradigm composite EROs between-group comparisons 
Group comparisons Est. Mean Difference 95% CI F (df) 
p value 






2. Controls Vs CPP -0.61 -1.02 to -0.19 
3. Controls Vs ARMS 0.24 -0.19 to 0.67 
4. Controls Vs Relatives -0.25 -0.61 to 0.12 
5. EPP Vs CPP  -0.04 -0.53 to 0.44 
6. EPP Vs ARMS 0.81 0.31 to 1.31 
7. EPP Vs Relatives 0.32 -0.12 to 0.77 
8. CPP Vs ARMS 0.85 0.38 to 1.33 
9. CPP Vs Relatives 0.36 -0.05 to 0.78 
10. ARMS Vs Relatives -0.49 -0.92 to -0.06 
Paired-click paradigm composite EROs (log transformed) mean differences between the study groups and 
95% confidence intervals, adjusted for multiple comparions. EROs values were log transformed to reduce the 
skewness of data before ANOVA comparisons EPP - early psychosis patients; CPP - chronic psychosis 
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5.8 Paired-click paradigm EROs and psychosis symptoms 
 
EROs gating and psychosis symptoms in early psychosis 
 
Figure 5.8 Scatter plot and fitted regression line showing the relationship between: a) low and high frequency 
EROs gating (Figure 5.4a) and PANSS negative symptoms scores in the early psychosis sample; 
 
Paired-click paradigm composite EROs as extracted above were regressed with PANSS 
scores in the early and chronic psychosis patients samples and there were no significant 
associations. However, S2/S1 EROs high and low frequency clusters selected for 
inclusion in the composite measure (depicted in Figure 5.4a) predicted, independently, 
PANSS negative symptoms scores (Figure 5.8, R2 linear=0.57, F=18.94, p<1.0e-5, high 
frequency cluster: β=0.49, t=3.95, p<0.001 and low frequency cluster: β=0.52, t=4.19, 
p<0.001), in the early psychosis sample, but not in the chronic psychosis sample. More 




Chapter five - Sensory gating paradigm EROs in psychosis 
85 
 
5.9 Paired-click paradigm composite EROs - genetic Vs chronicity 
effects 
 
Results in this chapter show first-degree relatives of psychosis patients did not differ 
from controls nor patients in paired-click paradigm composite EROs. First-degree 
relatives had an intermediate group mean value between controls and patients. Paired-
click paradigm composite EROs deficits were absent in the ARMS group, but present in 
both psychosis patients groups, with no significant difference between early and chronic 
patients. Together, this suggests paired-click paradigm composite EROs deficits are 
influenced by psychosis genetic vulnerability and psychosis onset, thereafter remaining 
stable over the longitudinal course of disease. This is further discussed in Chapter 7.  
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CHAPTER SIX  
RELATIONSHIPS BETWEEN ODDBALL 
TASK, PASSIVE ODDBALL AND PAIRED-
CLICK PARADIGMS EROS  
6.0 Introduction 
In this chapter, drawing from results in chapters 3, 4 and 5, EROs extracted from the 
oddball task, passive oddball and paired-click paradigms, are investigated with regards 
to their relationships, across the study groups. This is done in order to explore 
physiological links between the brain functions involved in each paradigm, as part of a 
broader attention-system and in an attempt to characterize the nature and course (genetic 
liability and disease effects) of neurophysiological abnormalities in psychosis. In 
addition, it is expected that combining EROs will produce larger differences between 
patients and controls, increasing the potential diagnostic aid utility of these measures. 
The relationships between the three paradigms EROs were investigated as the 
association between lower order, sensorial, brain functions measures: passive oddball 
and paired-click paradigms EROs and a higher order, cognitive function measure: 
oddball task EROs. 
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6.1 Relationships between oddball task, passive oddball and paired-
click paradigm EROs across study groups 
 
The ratio 
passive oddball paradigm EROs
paired−click paradigm EROs
 predicted oddball task EROs in controls, ARMS 
and first-degree relatives, but not in the two psychosis patients groups, F(1,242)=4.76, 
p<0.001 (Table 6.1). The interaction effect remained statistically significant when only 
controls and patients (early and chronic psychosis groups combined) were included in 
the GLM univariate model, F(1,141)=11.82, p<0.001. 
 
Table 6.1 | Associations between oddball task, passive oddball and paired-click 









Intercept 1.69 0.08 21.97 <0.001 1.54 1.84 
CPP -0.02 0.10 -0.22 0.83 -0.22 0.18 
EPP  0.04 0.12 0.30 0.77 -0.20 0.27 
Relatives  0.15 0.07 2.25 0.02 0.02 0.28 
ARMS 0.16 0.07 2.30 0.02 0.02 0.30 
Controls 0.26 0.06 4.22 <0.001 0.14 0.38 
GLM univariate parameter estimates for the interaction effect: Group * (
passive oddball paradigm EROs
paired−click paradigm EROs
) on 
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6.2 Combined oddball task, passive oddball and paired-click paradigm 
EROs across study groups 
 
The three paradigms EROs were standardized as z-scores and combined here as: oddball 
task EROs + passive oddball paradigm EROs - paired-click paradigm EROs. Passive 
oddball EROs were adjusted for age, before entering this calculation. This produces an 
index, "combined EROs", which would be reduced in psychosis patients, depending on 
their degree of impairment in all three paradigms brain functions and which reflects the 
relationships between these. Mean combined EROs for all the study groups are 
displayed in Table 6.2a. ANOVA between-group comparisons results are displayed in 
Table 6.2b and show a significant main effect for group: both psychosis patients groups 
had smaller combined EROs than controls and first-degree relatives groups. Chronic 
patients showed only a trend for smaller combined EROs than ARMS. There were no 
significant differences between controls, ARMS and first-degree relatives groups. There 
were no significant age, gender, smoking, nor lab main effects.  
Combined oddball task, passive oddball and paired-click paradigm EROs  
 
Figure 6.2a Mean three paradigms combined EROs and 95% 





Table 6.2a | Three paradigms 
combined EROs means 
Controls EPP   
0.21 (0.17) -1.04 (0.24)  
CPP  ARMS  Relatives 
-0.75 (0.22) 0.15 (0.27) 0.43 (0.17) 
Mean (se) three paradigms combined 
EROs for the study groups.  
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 Table 6.2b | Three paradigms combined EROs between-group comparisons 
Group comparisons Est. Mean Difference 95% CI F (df) 
p value 




9.65 (4,231)  
p<0.0001 
2. Controls Vs CPP 0.96 0.18 to 1.74 
3. Controls Vs ARMS 0.05 -0.84 to 0.95 
4. Controls Vs Relatives -0.22 -0.90 to 0.45 
5. EPP Vs CPP  -0.28 -1.20 to 0.62 
6. EPP Vs ARMS -1.19 -2.20 to -0.18 
7. EPP Vs Relatives -1.47 -2.29 to -0.65 
8. CPP Vs ARMS -0.90 -1.88 to 0.08 
9. CPP Vs Relatives -1.18 -1.97 to -0.40 
10. ARMS Vs Relatives -0.28 -1.18 to 0.62 
Three paradigms combined EROs mean differences between the study groups and 95% confidence intervals, adjusted 




ROC curve for the classification of psychosis patients Vs controls, obtained from 
logistic regression using the subtraction: oddball task EROs - paired-click paradigm 
EROs (z-scores),  as independent variable, is shown in Figure 6.2b. Passive oddball 
EROs were not included because they did not descriminate chronic psychosis patients 
from controls (chapter 4). The area under the curve is 0.77, with SE=0.04, 95% CI 0.70 
to 0.86, at the optimum ROC point: sensitivity = 0.76 and specificity = 0.72. 
Three paradigms combined EROs patients Vs controls discrimination 
 
Figure 6.2b ROC curve for EROs diagnostic properties. 
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6.3 Combined oddball task, passive oddball and paired-click paradigm 
EROs as an index of psychosis disease activity 
 
Combined oddball task, passive oddball and paired-click paradigms EROs are reduced 
in psychosis patients, irrespectively of whether they are at an early or chronic stage of 
the disease, when compared to controls and first-degree relatives. The left shift of 
patients groups combined EROs means in Figure 6.2a indicates a deficit in brain's 
overall ability to discriminate between incoming stimuli, either by attributing relevance 
and/or filtering irrelevant stimuli. That index could become an useful marker of 
psychosis active disease. Genetic liability influence and presumable brain function 
changes that take place during the leading period to full blown psychosis, are not 
directly reflected in that index, given that it did not differ between first-degree relatives, 
ARMS groups and controls. This is further discussed in chapter 7.  
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CHAPTER SEVEN  
OVERALL DISCUSSION AND FUTURE 
DIRECTIONS 
 
7.1 Summary and discussion of the main thesis findings 
 
In this thesis, I set out to evaluate the functional role of brain event related oscillations 
from the auditory oddball task, passive oddball and paired-click paradigms, with regards 
to selective attention, salience attribution and sensory gating brain functions. Following 
this, I looked at EROs abnormalities, as potential neurophysiological markers of 
psychosis genetic liability and psychosis disease onset/chronicity. In this chapter, I 
present a summary of the main results in this thesis, their interpretation and discussion:  
 
 Oddball task and passive oddball paradigms condition effects, when comparing 
target/deviant to non-target/standard tones brain EROs (Chapters 3 and 4), indicate 
target and deviance detection brain mechanisms depend on a pattern of increased 
EROs, followed by attenuated EROs, together with a fast-to-slow frequencies 
EROs transition. Hence, these dynamics can be used as neurophysiological markers 
of attention resources allocation and stimulus salience attribution. This fits with the 
evidence from previous studies describing similar aspects of brain function 
dynamics in the auditory oddball task (Fujimoto et al. 2012, Bernat et al. 2007, 
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Higashima et al. 2007, Mazaheri and Picton 2005, Haenschel et al. 2000, Traub et 
al. 1999).)  
 Larger low frequency (delta and theta range) brain EROs to targets and deviant 
tones, when compared to non-target and standard tones, were observed over the 
increasing amplitude ERP slope in the two oddball paradigms (Chapters 3 and 4), 
likely indexing underlying excitatory neuronal activity and allocation of brain 
resources to target and deviant tones stimulus processing (Yordanova et al. 2000). 
Functionally, low frequency brain EROs were negatively correlated with reaction 
time.   
 Smaller high frequency (alpha to gamma) brain EROs to targets and deviant tones, 
when compared to non-target and standard tones, were observed over the 
descending amplitude slope of the oddball paradigms ERP waveforms (Chapters 3 
and 4). Conversely, larger high frequency EROs to S2 were observed when 
compared to S1, in relation to sensory gating (Chapter 5). High frequency brain 
EROs are likely to index the strength of underlying inhibitory neuronal activity 
(Knyazev 2007, Turrigiano and Nelson 2004, Neuper and Pfurtscheller 2001, 
Pfurtscheller and Lopes da Silva 1999, Yordanova et al. 2001, Higashima et al. 
2007). Smaller high frequency brain EROs may be related to an increase in 
neuronal excitability following target and deviance detection, maximizing cortical 
areas prepairedness to process sensory infomation or execute motor commands; 
conversely, larger high frequency brain EROs, following repetitive stimuli, in the 
context of sensory gating, will decrease cortical excitability; accordingly, high 
frequency brain EROs in the two oddball paradigms were positively correlated with 
RT, whereas in the paired-click paradigm they were negatively correlated with RT 
(Chapters 3 to 5).   
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 Psychosis patients showed abnormal low frequency brain EROs both in the oddball 
task, in relation to selective attention cognitive demands, and in the paired-click 
paradigm, in relation to basic sensory processing (Chapters 3 and 5). This suggests 
that the impairment of different brain functions, at different complexity levels, 
occurs in psychosis through impact on brain low frequency oscillations, possibly 
implicating a common underlying pathophysiological mechanism (Hong et al. 
2012). This may reside on brain's ability to generate low frequency oscillations, 
which are thought to be involved in long-range synchronization between brain areas 
(von Stein and Sarnthein 2000) and is impaired in schizophrenia (Uhlhaas and 
Singer 2012). Abnormal catecholamine and glutamate activity have been associated 
to disruption of brain slow oscillations and could be a potential link to psychosis 
(Albrecth et al. 2012, Hong et al. 2010, Ehrlichman et al. 2009). 
 Genetic liability to psychosis induced brain EROs abnormalities in the passive 
oddball paradigm (Chapter 4). First-degree relatives showed increased passive 
oddball EROs, compared to controls and the other study groups, except chronic 
patients. A schizophrenia family study looking at the P3a  (a salience-related ERP) 
also found this to be increased in first-degree relatives (Michie et al. 2002). Passive 
oddball paradigm EROs increase, in subjects who are disease-free, is suggestive of 
a compensatory function. A higher salience threshold or salience range, which 
brains use to represent the environment, may protect against irrelevant events 
reaching awareness ("hypersalience"), similarly to what has been proposed for 
MMN (Todd et al. 2012) and ultimately result in less presynaptic striatal 
dopaminergic function (Howes and Kapur 2009). That could be achieved by 
increasing the gain of auditory cortex neurons (Rabinowitz et al. 2011). A 
systematic review of fMRI studies in first-degree relatives supported the existence 
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of compensatory changes in brain function (MacDonald et al. 2009); moreover, 
compensation takes place even in the normal ageing brain (Park and Reuter-Lorenz 
2009). However, further research is needed to test more fully this interpretation, as 
an alternative hypothesis would be that increased passive oddball EROs in fact 
represents an abnormal excessive brain response: "hypersalience". This alternative 
interpretation would require an explanation as to why did early psychosis patients 
show less "hypersalience" than chronic patients and their first-degree relatives, 
which could perhaps be attributed to medication effects. It is likely that there are 
also psychosis genes influences on sensory gating and oddball task paradigms 
EROs: first-degree relatives of psychosis patients showed no difference to controls 
nor patients in paired-click paradigm EROs, and their group mean value was 
intermediate between controls and patients; the difference between early psychosis 
patients and first-degree relatives oddball task EROs did not reach statistical 
significance, although there was a trend. These interpretations are, however, 
weakened by the lack of statistically significant differences between relatives and 
controls and the effects are only inferred from the pattern of means in controls, 
relatives and patients.  
Of note, theta-alpha frequency brain EROs gating has been shown impaired in 
schizophrenia patients first-degree relatives (Hong et al. 2008) and reduced 
attenuation of oddball tasks parietal alpha power has also been shown in 
adolescents at familial risk for schizophrenia (Kayser et al. 2014, Donkers et al. 
2011). That is in keeping with previous reports of P50 ratio and P300 deficits 
associated with psychosis genetic liability (see introduction). 
 Transition from ARMS to psychosis (the onset of psychosis) was linked to 
impairment in sensory gating EROs and these brain EROs were predictive of 
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patients’ symptoms in early psychosis (Chapter 5). The impairment of sensory 
gating, added upon a brain inability to increase its salience range (Chapter 4), may 
mark, in succession, the onset of psychosis. The onset of psychosis has previously 
been linked to deficient ERPs gating (van Tricht et al. 2012, Hsieh et al. 2012) and 
deficient activity of inhibitory cortical networks (Hasan et al. 2012). 
 Psychosis chronicity, as assessed by comparing brain function in early Vs chronic 
psychosis patients, was associated with an increase in passive oddball EROs, after 
adjustment for age (Chapter 4). With psychosis progression, the dependence of 
psychosis symptoms on brain EROs also changed from sensory gating to passive 
oddball EROs (Chapters 4 and 5). Studies using various investigation modalities 
have described brain functional and structural compensatory adaptations in 
schizophrenia, involving namely working memory and executive function networks 
(Faget-Agius et al. 2013, Koike et al. 2013, Barr et al. 2010, De Vico Fallani et al. 
2010, Minzenberg et al. 2009, Tan et al. 2007, Kindermann et al. 2004). Genetic 
expression patterns in the prefrontal cortex of schizophrenic subjects change from 
the early to chronic stages (Narayan et al. 2008). More broadly, adaptive changes in 
brain function could contribute to maintain neuropsychological performance, in the 
face of progressive neuroanatomical abnormalities in schizophrenia (Cobia et al. 
2012) and it is worth noting different subgroups of patients may follow different 
cognitive trajectories (Thompson et al. 2013), based for instance on the severity of 
psychosis primary deficits and available brain plasticity. Similarly to what has been 
shown for the P300 ERP (see introduction), increasing deficits in oddball task 
EROs may also occur with psychosis disease chronicity, because although early and 
chronic psychosis patients showed no statistically significant difference, the former 
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group unlike the latter did not reach a significant difference to the ARMs group 
(Chapter 3). 
 Figure 7.1 depicts a tentative model of changes in the studied auditory attention-
related brain EROs, along the psychosis stages. 
 
Attention-related brain EROs abnormalities in psychosis 
 
Figure 7.1 + indicates increase, - indicates loss, ↔ indicates no change, compared to the preceding stage. Salience 
range, sensory gating and selective attention brain functions are interpreted as reflected respectively by passive 
oddball, sensory gating and oddball task EROs. 
 
 Combining standardized brain EROs from the three studied paradigms (oddball task 
+ passive oddball - sensory gating EROs z-scores), showed that psychosis patients, 
but not first-degree relatives nor ARMS subjects, differed from controls in the 
overall balance between the studied brain functions (Chapter 6). This is compatible 
with the existence of compensatory brain changes in first-degree relatives and 
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ARMS groups, that maintain brain function within normal boundaries and 
consequently keep those subjects assymptomatic, despite psychosis genes influence 
or premorbid changes in brain function. Accordingly, first-degree relatives had an 
increased salience range in comparison with healthy controls (Chapter 4), whereas 
ARMS subjects had increased sensory gating strength compared to what would 
have been expected based on their psychosis genetic loading (Chapter 5). A relative 
increase in sensory gating could be adaptive in stimuli rich environments, however 
it could be detrimental for the appraisal of stimuli with low contrast, for example 
during sensory deprivation, where there is evidence of an increase in psychotic-like 
experiences in psychotic-prone individuals (Mason and Brady 2009). Sensory 
gating and salience brain functions may show a functional anti-correlated balance 
(Wyatt and Machado 2013), in feeding sensorial information to selective attention. 
The combined brain EROs ratio integrates influences on attention-related brain 
functions, from psychosis genetic liability, psychosis onset and progression, as well 
as brain compensatory effects. The combined brain EROs ratio can be interpreted 
as an overall index of psychosis disease expression and allostatic adaptations in the 
brain.  
 Assessing the relationships between the three studied paradigms shows an 
association between lower order, sensorial, brain functions measures: passive 
oddball and sensory gating EROs; and a higher order, cognitive function measure: 
oddball task EROs. These physiological links are disrupted in psychosis patients 
(Chapter 6). These relationships have been shown to be bidirectional: auditory 
stimulus novelty attribution recruits attention and vice versa, attention enhances 
auditory cortex responses to targets; brain gating/inhibitory mechanisms are 
involved in the formation of auditory sensory memory and also in top down 
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attentional control (Shinn-Cunningham 2008, Fritz et al. 2007, Jaaskelainen et al. 
2007, Ulanovsky et al. 2003, Melara et al. 2002). Psychosis patients' lack of 
integration between these brain functions could reflect poor connectivity between 
central hubs of the brain (Van den Heuvel et al. 2013, Nestor et al. 2007).  
 As reviewed above, the studied brain EROs showed mixed genetic and disease 
progression influences, which supports disease models that attempt to reconcile 
genetic and neurodegenerative theories, where genetic vulnerability and 
developmental insults, are interwoven with substance use, stress, dysregulation of 
HPA axis function and glutamate neurotoxicity, amongst other etiopathogenic 
factors (Stone et al. 2007, Pantelis et al. 2003, Keshavan 1999, Woods 1998). 
 On the whole, the studied brain EROs were more robust measures of psychosis 
disease expression than the respective paradigm's ERP, namely against the 
confounding effects of gender, age or lab. Unlike MMN and P50 ratio 
abnormalities which were found linked to psychosis in this study, P300 amplitude 
deficits (Bramon et al. 2004) were not replicated. This could be due to a number of 
factors: the use of a less stringent approach to EEG data inclusion, compared to 
other studies where some participants data was rejected based on ERP visual 
inspection criteria (Turetsky et al. 2015); the patients that were tested in this study 
were as a group and based on their mean PANSS  scores, not very symptomatic 
(Leucht et al. 2005), making the state dimension of P300 amplitude less altered 
(Mathalon et al. 2000); unmeasured confounders could have affected P300 
amplitude in controls, like ethnicity and drugs use (Turetsky et al. 2015).  
 Medication, in particular antipsychotics, could have influenced the measured brain 
EROs (Koch et al. 2015). Our study design, by comparing early to chronic 
psychosis patients, partly controls for that influence, because the two patients 
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samples were medicated, thus reducing the likelihood that differences between the 
two groups are due to medication effects. However, it cannot be ruled out the 
possibility that potential antipsychotics effects on brain EROs increased over time, 
given brain structure alterations were found to be correlated with cumulative 
exposure to antipsychotic treatments (Fusar-Poli et al. 2013). That would produce 
stronger effects in chronic, compared to early psychosis patients. But if indeed 
medication was to have a progressive effect on the studied brain EROs, then this 
would not be equal across them: whereas passive oddball EROs differed between 
early psychosis and chronic psychosis patients, paired-click paradigm EROs did 
not. Also of note, antipsychotic effects could not explain the brain EROs 
differences found between ARMS, first-degree relatives or controls (e.g: first-
degree relatives had larger passive oddball paradigm EROs than ARMS and 
controls), given none of these groups were medicated. Previous studies on brain 
EROs in schizophrenia have found deficits that were independent of medication 
status, by comparing unmedicated to medicated patients and controls (Sun et al. 
2013, Minzenberg et al. 2010, Gallinat et al. 2004) and which were genetically 
determined, by looking at monozygotic twin pairs discordant for schizophrenia 
(Hall et al. 2011). Similar study designs could be used in the, future looking at the 
studied brain EROs, in order to elucidate potential medication effects. 
 There are other limitations to this study: it would be necessary to track brain event 
related oscillations longitudinally, on cohorts of subjects identified based on risk 
factors as more prone to develop psychosis, from early childhood, through onset 
and years of duration of disease, in order to provide unequivocal evidence of brain 
EROs genetic, developmental as well as progressive changes in psychosis. Only 
one electrode per paradigm was analyzed in this study, hence topographical effects 
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and brain sources were not investigated; this approach, however, minimized the 
problem of multiple comparisons and facilitates future translation to clinical 
application by making data collection/analysis simpler.  
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7.2 Conclusions and future directions 
 
This thesis brings insights into brain physiological mechanisms underlying selective 
attention resources allocation, stimuli salience attribution, sensory gating and the 
specific abnormalities in those dynamics that are associated to psychosis disease and its 
symptoms. It also sheds light on the impact of psychosis vulnerability genes and 
psychosis disease progression on brain function and how the brain might develop 
compensatory adaptations. This knowledge could have impact on the wider psychosis 
research field. Further work, beyond the scope of this thesis, could be undertaken on the 
study sample investigated here and/or a larger sample, by including subjects from whom 
colleagues have retrieved more data. There would be value in examining brain EROs 
topographical effects and exploring other types of metrics, including EEG source and 
connectivity analysis. It would be most interesting to bridge the gap between brain 
function measures described here and candidate genes for psychosis. As discussed 
earlier, studies with different designs are needed to fully disentangle genetic and 
progressive disease influences on brain function. Studies designed to test the ability of 
the EROs measures developed in this thesis in predicting prognosis and response to 
treatment could give evidence for their direct clinical applicability. With the same end 
in mind, studying EROs in samples of different psychiatric populations could reveal 
diagnostic utility. Finally, the understanding of the functional role of EROs in the 
studied paradigms could lead to applications outside the clinical remit and be used for 
example to assess brain function in healthy subjects whilst performing tasks in work or 
leisure environments. It is hoped that this thesis contributes to the advance in this field 
of research and that this may translate into clinical applications that ultimately will 
improve patients lives. 
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BACKGROUND: Event-Related Oscillations (EROs) have been linked to cognition and found 
to be abnormal in psychotic disorders. It is unclear if EROs deficits reflect genetic liability to 
psychosis, the onset and/or progression of psychosis disease.  
METHODS: 35 early psychosis and 44 chronic psychosis patients, 69 unaffected first-degree 
relatives, 40 subjects with 'at risk mental state' (ARMS) and 76 healthy controls were included 
in this study. Subjects underwent electroencephalography recording during an auditory oddball 
task, a duration-deviant passive oddball paradigm, and a paired-click paradigm, which elicit 
selective attention, salience detection and sensory gating brain processes respectively. Wavelet-
based time-frequency analyses were conducted to extract single trial EROs. Relevant EROs 
were identified by examining EROs condition effects, EROs associations with reaction time and 
EROs differences between patients and controls, through cluster-based t-tests and regression 
analysis. EROs were compared between groups using ANOVA, regressed to test relationships 
between the three paradigms and associations with psychosis symptoms scores. 
RESULTS: Selective attention EROs were influenced by psychosis disease progression, 
salience EROs by disease chronicity and sensory gating EROs by disease onset. The three EROs 
types were also influenced by psychosis genetic liability. Psychosis symptoms were predicted 
by sensory gating and salience EROs in early and chronic patients, respectively. Stronger 
salience and gating EROs combined predicted stronger selective attention EROs in all groups, 
except in psychosis patients. First-degree relatives and ARMS subjects showed evidence of 
EROs compensatory changes. 
CONCLUSIONS: In psychosis, attention-related EROs reflect genetic vulnerability, disease 
onset and progression, together with brain compensatory adaptations and ageing. 
 
  





Schizophrenia is a chronic severe mental illness leading to impaired cognition and functioning. 
The neurodevelopmental model posits that it is the outcome of abnormalities in maturational 
processes caused by genetic and environmental factors (1-3). The Kraepelin model, on the other 
hand, emphasizes neurodegenerative changes, taking place after disease onset, resulting in 
gradual decline of cognitive and social functioning (4). Brain function abnormalities which are 
stable over time, presenting even before the onset of schizophrenia, could reflect genetic 
liability and be used as endophenotypes  (5), whereas biomarkers correlating with psychosis 
severity could be valuable in its clinical staging, providing insights into treatment and prognosis 
(6, 7). Event related oscillations (EROs) mediate sensory, cognitive processes (8) and are 
affected in schizophrenia (9-13). Different EROs time-frequencies reflect distinct brain 
functions and may be impaired by different disease mechanisms, therefore measuring and 
integrating multiple EROs is necessary in order to unravel schizophrenia complex 
neurophysiological abnormalities (9-14). There are well established neurophysiological 
impairments in schizophrenia, elicited by the auditory oddball task (15-17), passive oddball (16, 
18-21) and paired-click gating paradigms (16, 22-24), from which the P300, mismatch 
negativity (MMN) event related potentials and P50/N100 gating are traditionally measured. 
These paradigms involve different brain functions: the oddball task is linked to cognitive 
information processing, including memory, attention and executive functions (25, 26); the 
passive oddball produces an involuntary attention-call signal to auditory change (27); the 
paired-click paradigm elicits sensory gating, testing the brain's ability to filter incoming 
irrelevant stimuli and focus attention (28). Fewer studies have looked at these paradigms' EROs 
and their abnormalities in schizophrenia: chronic schizophrenia patients had deficits in oddball 
task delta and theta EROs, that were associated with decreased P300 amplitude, (29-31); 
dependence of MMN on theta band oscillations was shown in healthy subjects (32) and using 
the same paradigm, theta-alpha range oscillations were abnormally enhanced in chronic 
schizophrenia patients (33); in the sensory gating paradigm, EROs reductions in theta/alpha (34, 
35) and beta (36) bands contributed to decreased P50 or N100 gating in schizophrenia patients. 




Preliminary evidence shows that EROs tap onto psychosis genetic vulnerability: the early 
auditory evoked gamma-band response (37-39) and theta-alpha frequency EROs gating (40) 
were found abnormal both in schizophrenia patients and in their first-degree relatives. Although 
there is evidence of psychosis progression effects on P300, MMN and P50 ratio (41-51), this 
has not yet been investigated for the respective paradigms EROs, to our knowledge. It is also 
unknown if EROs from the oddball task, passive oddball and gating paradigms are related, even 
if a few studies have linked their ERPs (52-54). Arguably, the attention system and its key 
mechanism of salience detection (55), a core element of schizophrenia etiopathogenesis (56), is 
a common factor modulating brain’s reactions across the oddball task (57), passive oddball (58) 
and sensory gating paradigms (59-61). Moreover, combining different neurophysiological 
paradigms on the same sample of patients can provide complementary information, helping to 
characterize the population more accurately (62, 63). 
The main aims of this study were to investigate the neurophysiology of attention-related 
auditory EROs and how these are affected by psychosis genetic liability, disease onset and 
progression. We hypothesized that genetically linked EROs abnormalities would be present in 
first-degree relatives. We hypothesized that the onset and progression of psychosis, from 
ARMS, through early psychosis to chronic psychosis, would be associated with increasing 
EROs abnormalities.  
 
METHODS AND MATERIALS 
Participants 
We used a cross-sectional design comparing 5 groups: an early psychosis sample, 35 individuals 
between 18-35 years old with a DSM-IV diagnosis of a psychotic disorder with an onset of 
psychotic symptoms less than 5 years previously; a sample of 44 chronic patients diagnosed 
with schizophrenia or schizoaffective disorder; a ARMS sample of 40 subjects with an "at risk 
mental state" (ARMS), according to criteria established by Yung and colleagues (64); a sample 
of 69 first-degree relatives of psychosis patients; another sample of 76 controls without a 
personal or family history of psychotic disorder. Most participants (controls, ARMS and early 




psychosis patients) were recruited individually, however a part of the chronic patients and 
relatives groups were recruited for a family study (21, 43): of the 264 participants, 181 (68.6%) 
were singletons, 58 (22.0%) were part of families with two members in the study, 21 (8,0%) 
were in three-person families, and 4 (1.5%) were in one four-person family. A history of 
neurological disorders, head injury with loss of consciousness longer than a couple of minutes 
or a DSM-IV diagnosis of alcohol or illegal substance dependence in the 12 months prior to 
assessment were exclusion criteria across all the subjects groups. Demographic and clinical data 
are summarized in table 1. All participants gave written informed consent to enter the study. 
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Tasks, EEG recordings and EROs measurements 
EEG data was recorded using a 40-channel electrode cap positioned according to the 10/20 
International System referenced to linked mastoids and grounded at Fpz, with all electrode 
impedances kept at under 5kΩ. Data was continuously digitised at 1000 Hz with a digital 0.1-
100 Hz band pass filter (24 dB/octave roll-off). The continuous EEG was segmented offline into 
large epochs time-locked to auditory stimuli (–3100 to 2500 ms), in order to allow analysis of 
low frequency bands and minimize edge effects. Artefact rejection was performed to reject data 
segments containing eye blinks, muscle artefacts and amplitudes exceeding +/- 100 μV.  Line 
noise removal was performed at 50Hz using a discrete Fourier transform. 
Data were registered while subjects performed 3 experiments, in this order: auditory oddball 
task, passive oddball and paired-click paradigms. Their duration was approximately 15, 6 and 
20-25 minutes, respectively. The oddball task (65) consisted of one block of four hundred tones, 
with a 2 second (±0.2 second) inter-stimulus interval, 80% of the tones were ‘non-targets’ of 
1000 Hz and 20% were ‘targets’ of 1500 Hz. Subjects were instructed to a press a button with 
their preferred hand when identifying a target. Reaction time (RT) was measured as the median 
button press response latency to target tones, in milliseconds and response accuracy was 
calculated as the percentage of correctly identified targets. The passive oddball paradigm (21) 
consisted of three blocks of 400 stimuli (0.3 sec inter-stimulus interval) with 85% standards (25 
ms, 1000 Hz, 5-ms rise/fall time) and 15% duration deviants (50 ms duration, 5 ms rise/fall 
time). Tones had an intensity of 80dB in both tasks. Finally, four or five blocks of 30 pairs of 
conditioning (S1) and test (S2) clicks were obtained (66), with stimulus adjusted individually to 
43 dB above the hearing threshold. S1 and S2 were of 1 ms duration and separated by 500 ms. 
Intertrial intervals between click pairs were 10 seconds. Subjects were requested not to smoke at 
least 30 minutes before data collection (67).  
Time-frequency analyses from single trials were performed using Morlet wavelets with a 'width' 
of 4 (12), power was extracted with a 1 Hz (frequency) and 1 msec (time) resolution for baseline 
and post-stimuli intervals. The EEG frequency bands of interest were Delta (1-3Hz), Theta (4-
7Hz), Alpha (8-12Hz), Beta (13-30Hz) and Gamma (31-100Hz). For EROs calculation, relative 
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baseline correction (the quotient of post stimuli power over baseline average power) was 
applied and baseline lengths were determined separately for each band: Delta (-1000 to 0 ms), 
Theta (-250 to 0 ms), Alpha (-125 to 0 ms), Beta (-100 to 0 ms), Gamma (-50 to 0 ms). Hence, 
EROs represent the post-stimuli relative change of power in comparison to the baseline. 
EROs of interest were those with a functional link to: a) task (condition) effects; or b) 
behavioural performance, as measured by oddball task reaction time (RT); or that would c) 
discriminate between patients and controls. To identify these EROs, t-test comparisons were 
performed between each paradigm's two stimuli EROs time-frequency spectrums (Figures 1a-c), 
between controls and patients (Figure 1g-h) and EROs time-frequency spectrums were 
regressed with RT and PANSS scores (Figures 1d-f), creating time-frequency maps with 
clusters of statistically significant t-test scores and regression coefficients (68). These clusters 
were mapped onto target tone, deviant tone and S2/S1 EROs time-frequency spectrums, to 
delimitate EROs of interest. Composite EROs ratios were calculated for each paradigm, by 
combining EROs across frequencies, following the same rational as others investigating EEG 
markers of attention and cognition (69-76). The aim was to make composite 
EROs measures reflect psychosis impairments in: 1) isolated EROs time-frequency clusters; 
and/or 2) EROs "collective behaviour", as ensembles of EROs time-frequency clusters that are 
functionally linked in each studied paradigm. This approach allows to establish functional links 
between different EROs and thus integrate different brain processes, as argued by various 
authors (9-12).  
EROs were extracted from each paradigm as follows: Oddball-task-EROs - from the target tone 
EROs spectrum, a ratio was calculated between EROs mapped taking maximum values from the 
positive and negative clusters in Figure 1d: (
𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑙𝑢𝑠𝑡𝑒𝑟𝑠 𝐸𝑅𝑂𝑠
𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝐸𝑅𝑂𝑠
); this ratio was weighed 
(multiplied) by the maximum EROs value within the boundaries defined by the delta/theta 
cluster in Figure 1g. Passive-oddball-EROs - from the deviant tone EROs spectrum, a ratio was 




). Paired-click-EROs: S2/S1 EROs spectrum was computed; 
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from this, a ratio was calculated between maximum S2/S1 values mapped by the positive and 
negative clusters in Figure 1f: (
𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝐸𝑅𝑂𝑠
𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑙𝑢𝑠𝑡𝑒𝑟𝑠 𝐸𝑅𝑂𝑠
); this ratio was weighed (multiplied) by 
the minimum S2/S1 EROs value within the boundaries defined by the theta cluster in Figure 1h. 
These EROs were combined between all 3 paradigms in one index (c_EROs), after being 
converted into standardized z-scores, as: oddball-task-EROs + passive-oddball-EROs - paired-
click-EROs. Passive-oddball-EROs were adjusted for age, before entering this calculation.  
ANOVA, including gender and age as covariates, was conducted for each individual paradigm 
extracted EROs and c_EROs; EROs correlations within families were controlled for by use of a 
random effect. Extreme outliers (3xIQR below 1st quartile or above 3rd quartile, totalling less 
than 3 subjects/group) were excluded. A significant ANOVA overall test was followed up by 
multiple pairwise comparisons, with tukey-kramer correction for experiment-wise error rate. 




as independent variable and oddball-task-EROs as dependent variable, was used to test the 
relationship between lower level and higher level EROs across study groups. The three 
paradigms EROs were introduced together in regression analysis to predict PANSS positive and 




Mean target tone response accuracy and RT for each study group are displayed in table 1. There 
were no statistically significant group differences for target tone response accuracy. There was a 
group effect on RT, (F(4,260) = 6.83, p<0.0001), controls were faster than early psychosis 
patients (∆ = -117ms, 95% CI = -182 to -52ms) and chronic psychosis patients (∆ = -68ms, 95% 
CI = -129 to -7ms), but showed no difference to ARMS nor first-degree relatives groups. Men 
had faster RT than women, F(1,260) = 12.24, p<0.001, ∆ = -49ms, 95% CI = -78 to -19ms. 
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Time-frequency analysis by test condition and associations with reaction time  
The condition effects (tone types comparisons) for the 3 studied paradigms in the overall study 
sample (all subjects combined) are shown in Figures 1a-c t-test scores. Oddball task target tones 
elicited larger EROs in the delta/theta frequency range and in the late gamma range, but smaller 
alpha EROs than non-target tones (Figure 1a). Linear regression coefficients in Figure 1d show 
a negative cluster associating target tone early gamma/delta/theta EROs with RT. Conversely, 
later target tone gamma, alpha/beta EROs clusters were positively associated with RT. As such, 
smaller early gamma/low frequency EROs and larger late alpha/beta EROs were markers of 
slower RT. Passive oddball deviant tones elicited larger early gamma and delta/theta EROs, but 
smaller late beta EROs than standard tones (Figure 1b). Linear regression coefficients in Figure 
1e show the association between patients' deviant minus standard tone EROs difference and RT; 
as that difference increases in an early gamma and theta frequency windows, RT is faster and as 
that difference is smaller in a late beta frequency window, RT is slower. In the paired-click 
paradigm, S1 elicited larger delta/theta EROs but smaller gamma EROs than S2 (Figure 1c). 
Linear regression coefficients in Figure 1f show the association between patients' S2/S1 EROs 
ratio and RT; smaller S2/S1 low frequency EROs ratio is linked to slower RT, whereas larger 
S2/S1 high frequency EROs ratio is linked to faster RT. 
Controls Vs patients EROs spectrums comparisons  
In the oddball task, t-test scores in Figure 1g show reduced target tone delta/theta EROs in 
patients compared to controls. In the passive oddball paradigm, deviant tones EROs spectrums 
did not differ between patients and controls. Controls showed smaller S2/S1 theta EROs ratios 
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Results of between-group comparisons for extracted EROs are displayed in Figure 2. We found 
significant group effects on oddball-task-EROs, F(4,260)=5.45, p=3.0e-4, passive-oddball-
EROs, F(4,246)=4.7, p=0.001, paired-click-EROs, F(4,250)=9.10, p=7.1e-7 and c_EROs, 
F(4,230)=9.65, p=3.2e-7. Passive-oddball-EROs decreased with increasing age in the overall 
sample (F(1,246)=9.35, p=0.002, β=-0.16). Gender had no effect on any of the studied 
paradigms extracted EROs. On post-hoc pairwise comparisons (Figure 2 sub-tables), controls 
showed larger oddball-task-EROs than early psychosis patients and chronic psychosis patients, 
but no significant difference to ARMS or relatives groups. ARMS subjects showed larger 
oddball-task-EROs than chronic psychosis patients, but not early psychosis patients. There was 
a trend for larger passive-oddball-EROs in controls, compared to early psychosis patients. First-
degree relatives showed larger passive-oddball-EROs than controls, early psychosis patients and 
ARMS groups, but no significant difference to chronic psychosis patients. Early psychosis 
patients showed smaller passive-oddball-EROs than chronic psychosis patients but no 
significant difference to the ARMS group. Controls had stronger paired-click-EROs than early 
and chronic psychosis patients. ARMS subjects had stronger gating than early psychosis 
patients, chronic psychosis patients and first-degree relatives. The latter group gating mean was 
intermediate between controls and patients, but did not statistically differ from them. Both 
psychosis patients groups, but not ARMS nor first-degree relatives had smaller combined EROs 
than controls. 
Scatter plots in Figures 2e-f, with fitted regression lines, show the relationship between paired-
click-EROs, passive-oddball-EROs and negative psychosis symptoms in early psychosis (R2 
linear=0.57, r= 0.66, p<0.0001) and chronic psychosis (R2 linear=0.21, r= 0.46, p<0.01) 
patients, respectively. No significant association was found between extracted EROs and 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Relationship between oddball task, passive oddball and sensory gating EROs 
The ratio 
passive oddball paradigm EROs
sensory gating paradigm EROs
 predicted oddball task EROs in controls, ARMS and first-
degree relatives, but not in the two psychosis patients groups, F(1,242)=4.76, p<0.001 (Table 2). 
The interaction effect remained statistically significant when only controls and patients (early 
and chronic psychosis groups combined) were included in the GLM univariate model, 
F(1,141)=11.82, p<0.001. 
Table 2. Associations between oddball task, passive oddball and sensory 









Intercept 1.69 0.08 21.97 <0.001 1.54 1.84 
CPP -0.02 0.10 -0.22 0.83 -0.22 0.18 
EPP  0.04 0.12 0.30 0.77 -0.20 0.27 
Relatives  0.15 0.07 2.25 0.02 0.02 0.28 
ARMS 0.16 0.07 2.30 0.02 0.02 0.30 
Controls 0.26 0.06 4.22 <0.001 0.14 0.38 




on oddball task EROs. EPP - early psychosis patients; CPP - chronic psychosis patients; ARMS - 'At 
risk mental state' subjects. 
 
DISCUSSION  
In this study, we have looked at auditory event related oscillatory power across different tasks, 
with a view to differentiating brain function profiles at different stages of the psychosis 
spectrum and psychosis genetic liability. We identified EROs markers of selective attention, 
salience and sensory gating brain responses, measured from the oddball task, passive oddball 
and paired-click paradigms, respectively. The three paradigms EROs were linked, except in the 
psychosis patients groups, where this link was disrupted (table 2), possibly reflecting poor 
functional connectivity between central hubs of the brain (77, 78). The links between the studied 
paradigms EROs are likely bidirectional: auditory stimulus novelty attribution recruits attention 
and vice versa, attention enhances auditory cortex responses to targets; brain gating/inhibitory 
mechanisms are involved in the formation of auditory sensory memory and also in top down 
attentional control (79-83). 
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Our results indicate oddball-task-EROs may be reduced by psychosis genetic liability, disease 
onset and progression altogether, making oddball-task-EROs a marker of overall psychosis 
deficits. Oddball-task-EROs were impaired following psychosis disease onset (patients 
compared to controls); they appeared to deteriorate over the longitudinal course of the disease, 
given chronic psychosis patients, unlike early psychosis patients, differed from the ARMS 
group; and also be reduced by genetic influence, given the difference between early psychosis 
patients and first-degree relatives also did not reach statistical significance (Figure 2a). Our 
results revealed increased salience EROs in first-degree relatives of psychosis patients (Figure 
2b). Similarly, a schizophrenia family study looking at the P3a found this to be increased in 
first-degree relatives (84). The salience EROs increase, in disease-free subjects, is suggestive of 
compensatory brain activity, which could be achieved through an increase in the gain of 
auditory cortex neurons (85). A systematic review of fMRI studies in first-degree relatives 
supported the existence of compensatory changes in brain function (86); in fact, compensation 
exists even in the normal ageing brain (87). Early psychosis and ARMS subjects had smaller 
salience EROs compared to first-degree relatives, indicating a failure to develop and/or the 
breakdown of that compensatory brain activity. A lower salience threshold/range, with which 
brains represent the environment, may result in irrelevant events reaching awareness more often 
("hypersalience"), similarly to what has been proposed for MMN (58), and ultimately increased 
presynaptic striatal dopaminergic function (88). Following from the above, passive-oddball-
EROs might prove valuable as a proxy measure of psychosis genetic loading in first-degree 
relatives and as a means to assessing brain function (de)compensation status in patients. In 
addition, because passive-oddball-EROs decrease with ageing in our overall sample, they may 
index cognitive decline and deficient N-methyl-d-aspartate (NMDA) receptor functioning, 
likewise MMN (89). It would be expected for ARMS subjects to show, as a group, psychosis 
genes associated deficits in brain function (90, 91), however, we found instead that paired-click-
EROs were stronger in ARMS subjects compared to first-degree relatives (Figure 2c). Whereas 
first-degree relatives brains could increase salience EROs to compensate for the genetic 
influence on oddball-task EROs, ARMS subjects brains could compensate that by increasing 
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sensory gating. Paired-click-EROs and passive-oddball-EROs may show a physiological 
balance (92), that could keep first-degree relatives and ARMS subjects' attention system 
functioning within normal limits. The loss of sensory gating compensation may constitute a 
second "hit" to brain function and mark the transition from the prodrome to psychosis (Figure 
2c). In this respect, paired-click-EROs could become a useful biomarker of transition to 
psychosis. This transition has previously been linked to deficient ERPs gating (93, 94) and 
deficient activity of inhibitory cortical networks (95). In this study, progression from an early to 
chronic psychosis stage, led to larger age-adjusted salience EROs in patients (Figure 2b) and 
psychosis symptoms dependence on these EROs, rather than paired-click-EROs (Figures 2e-f). 
Brain functional and structural adaptations in schizophrenia, involving namely working memory 
and executive function networks, have been shown using various investigation modalities (96-
102). Genetic expression patterns in the prefrontal cortex of schizophrenic subjects change from 
the early to chronic stages (103). More broadly, adaptive changes in brain function could 
contribute to maintain neuropsychological performance, in the face of progressive 
neuroanatomical abnormalities in schizophrenia (104). Figure 3 represents a summary model of 
attention-related EROs changes associated to psychosis. 
Figure 3. Attention-related EROs abnormalities in psychosis 
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Because the studied EROs showed multiple psychosis associated influences, our results support 
disease models that attempt to reconcile genetic and neurodegenerative theories, where genetic 
vulnerability and progressive developmental insults, are interwoven with substance use, stress, 
dysregulation of HPA axis function and glutamate neurotoxicity, amongst other etiopathogenic 
factors (105-109).  
This study has limitations, which include the fact that we used a cross sectional design, whereas 
longitudinal within-subject studies following up patients from as early as before the prodromal 
stage and long after disease onset, would provide stronger evidence of genetic and/or disease 
influences on brain function. We did not control for medication effects, nor correct for the 
number of statistical comparisons in all the analyses, treating each paradigm independently. 
In conclusion, in psychosis attention-related neurophysiological markers are influenced by 
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Background: Brain Event-Related Oscillations (EROs) have been established as 
neurophysiological markers of cognitive function. Three auditory paradigms, classically used to 
elicit the P300 and Mismatch Negativity (MMN) components and P50 gating, share links to 
attention function and have shown impairments in schizophrenia. We hypothesized that early 
psychosis patients would show auditory EROs deficits and these would be associated to 
psychosis symptoms and illness duration. 
Methods: Patients with early psychosis (n=35) and gender/age-matched controls (n=35) 
underwent electroencephalography recording during an auditory oddball task, a duration-deviant 
MMN paradigm, and a paired-click paradigm. Wavelet-based time-frequency analyses were 
conducted to assess single trial power. Relevant EROs clusters were identified by examining 
EROs task (condition) effects, associations between EROs and reaction time (RT) and EROs 
differences between groups, through cluster based t-tests and regression analysis. EROs 
measures from all three paradigms were compared between groups using ANOVA and 
regressed with psychosis symptoms and illness duration. 
Results: Early psychosis patients showed reduced oddball task, passive oddball EROs, as well 
as paired-click paradigm EROs gating, respectively markers of selective attention, salience and 
sensory gating. The ratio 
passive oddball EROs
𝑙𝑜𝑤 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝐸𝑅𝑂𝑠 𝑔𝑎𝑡𝑖𝑛𝑔
 predicted oddball task EROs in controls, but 
not in patients. EROs gating increased with age in controls, but not in patients. The ratio 
oddball task EROs
𝑙𝑜𝑤 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝐸𝑅𝑂𝑠 𝑔𝑎𝑡𝑖𝑛𝑔
 increased with psychosis illness duration. EROs gating predicted 
PANSS negative symptoms.  
Conclusions: In early psychosis, attention-related auditory EROs are impaired, show abnormal 
brain maturation and reflect psychopathology, but also indicate partial recovery in brain 
function.  
  





Event-related brain oscillations (EROs) correspond to changes in the frequency spectrum of the 
ongoing electroencephalogram (EEG), triggered by events such as an auditory stimulus. EROs 
amplitude (or power) can be measured for specific frequency bands with a millisecond time 
resolution. Time-frequency decomposition of single trials provides a measure of power that is 
not phase locked to the stimulus onset, complementing the information provided by ERPs (1).  
EROs have been correlated with different aspects of cognition (2). While the study of EROs in 
schizophrenia has received increasing interest in recent years (3-7), neurophysiological studies 
in schizophrenia have mostly looked at event related potentials (ERP), particularly using 
auditory P300 (8), P50 gating (8-10) and mismatch negativity (MMN) (11-13), all of which 
affected in psychosis patients. The P300 is linked to cognitive information processing, including 
memory, attention and executive functions (14, 15); P50 ratio measures brain sensory gating, its 
ability to filter incoming irrelevant stimuli and focus attention (16); MMN measures an 
involuntary attention-call signal to auditory change (17). Arguably, attention and its key 
mechanism of salience detection (18), a core element of schizophrenia etiopathogenesis (19), 
modulate brain’s reactions in the oddball task (20), passive oddball (21) and paired-click 
paradigms (22, 23). Moreover, combining different neurophysiological paradigms on the same 
sample of patients is potentially advantageous, because they can complement each other and 
characterize the population more accurately (24, 25). There have been reports of associations 
between MMN-P300 (26, 27) and P50 gating-MMN (26, 28) deficits in schizophrenia.  
Previous studies in chronic patients with schizophrenia have found power reductions in delta 
and theta bands in the auditory oddball target detection paradigm that are associated with 
decreased P300 amplitude (29-31). In the paired-click paradigm, EEG power reductions in 
theta/alpha (32, 33) and beta (34) frequency bands contributed to decreased P50 or N100 gating 
in schizophrenia patients. Dependence of MMN amplitude on theta band oscillations has been 
shown in healthy subjects (35), and MMN theta-alpha range oscillations were abnormally 
enhanced in chronic schizophrenia patients (36). However, as these studies of EROs have 
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mostly been conducted in chronic patients, the status of attention-related EROs in early 
psychosis remains uncertain. Finding biomarkers of psychosis in this critical disease period, 
could prove valuable for instance in guiding diagnosis and treatment interventions after a first 
psychotic episode. Our study hypotheses were: 1) Selective attention, salience detection and 
sensory gating EROs are impaired in early psychosis patients, 2) influenced by psychosis illness 





35 participants between 18-35 years old meeting DSM-IV criteria for a psychotic disorder (see 
Table 1) with an onset of psychotic symptoms within the past 5 years were recruited from the 
early intervention services at the South London and Maudsley NHS Foundation Trust. Another 
35 age and gender matched controls without a family history of psychosis were recruited from 
the same geographical area as the patients. Control volunteers were not excluded for a personal 
history of other non-psychotic DSM-IV diagnoses, provided the volunteer had been well and 
free from any psychotropic medication for at least 12 months prior to study entry. Patient and 
control participants were excluded if they had a history of neurological disorders, head injury 
with loss of consciousness longer than a couple of minutes or a DSM-IV diagnosis of alcohol or 
illegal substance dependence in the 12 months prior to study entry. Demographic and clinical 
data are summarized in Table 1. All participants gave written informed consent to enter the 
study. This research was approved by the Ethical Committee at the Institute of Psychiatry. 
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   Test(df) p value 
Sex (% Male) 67 74 χ2(1)=0.5 0.47 
Mean Age, years (SD) 25.0(4.4) 24.9(4.1) t=0.1 0.88 
Smoking status, % smokers 4.8 73.5 χ2(1)=38.8 <0.001 
P300 amplitude (Pz) 11.8(6.6) µV 8.8(6.2) µV (appendix Figure 2a) 
Reaction Time (RT) 422(110) ms 507(176) ms t=-2.5, ∆=-90ms, 95% 
CI=-161 to -18ms, 
p=0.01 
Target response accuracy 95(6.7) % 91(9.1) % t=-1.2, Δ=2.4%, 95% 
CI=-1.5 to 6.3 %, 
p=0.22 
MMN amplitude (Fz) -4.0(3.6) µV -2.9(3.3) µV (appendix Figure 2b) 
P50 gating (Cz) S2/S1 0.52(0.35) 0.81(0.69) t=-2.09, ∆=-0.29, 95% 
CI=-0.56 to -0.01, 
p=0.04 
Patients DSM-IV Diagnosis  Paranoid Schizophrenia (22) 
Bipolar I disorder (5) 
Schizophreniform disorder (3) 
Acute and transient Psychotic disorder (3) 
Schizoaffective disorder (1) 
Major Depressive Disorder with Psychotic features (1) 
Patients duration of illness in 
months - mean (SD)  
23.2 (15.4) 
Psychotropic Medication 











No medication (6) 
PANSS PS 10.3 (3.9)  
NS 18.2 (8.3)  
GS 29.3 (8.2)  
TS 57.8 (17.8)  
Values for categorical variables are shown as frequency (N) and for continuous variables as Mean (Standard 
Deviation). Comparisons were performed using t-test for continuous and chi-square for categorical variables; 95% 
confidence intervals (CI) are presented; df – degrees of freedom; SD - standard deviation. PANSS, Positive and 




EEG data was recorded using a 40-channel Quik-Cap electrode cap positioned according to the 
10/20 International System referenced to linked mastoids and grounded at Fpz, a SCAN 
NuAmps ExpressTM 40-channel monopolar digital amplifier and SCAN software package 
version 4.3 (Compumedics Neuroscan, Texas, USA). Eye movements were recorded from the 
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outer canthus of each eye and above and below the right eye. Electrode impedances were below 
5 kΩ. Data were continuously digitised at 1000 Hz with a digital 0.1-100 Hz band pass filter (24 
dB/octave roll-off). Subjects were asked not to smoke for at least 30 minutes before data 
collection (37). Data analysis was performed offline using the Matlab-based FieldTrip toolbox 
(http://fieldtrip.fcdonders.nl/). Continuous EEG data were segmented into large epochs time-
locked to auditory stimuli (–3100 to 2500 ms), in order to allow analysis of low frequency 
bands and minimize edge effects. Artefact rejection was performed to reject data segments 
containing eye blinks, muscle artefacts and amplitudes exceeding +/- 100 μV.  Line noise 
removal was performed at 50Hz using a discrete Fourier transform.  
Participants performed an auditory oddball task (38, 39) using one block of four hundred 80 dB 
tones presented through bilateral earphones, with a 2 second (±0.2 second) inter-stimulus 
interval. The tones comprised a random sequence of 80% ‘standards’ (1000 Hz) and 20% 
‘targets’ (1500 Hz). Subjects were instructed to press a button with their preferred hand in 
response to target tones only. Trials with correctly identified target tones were used for analysis. 
To yield the target ERP waveforms the EEG was digitally filtered (0.05–40 Hz) and baseline 
corrected (–50 to 0 ms), then epochs were averaged. P300 peak amplitude was measured at Pz, 
calculating the peak (between 250 to 400ms) to preceding trough difference.  
A passive oddball (duration-deviant MMN paradigm) was carried out (13) whilst subjects were 
instructed to remain still and quiet, keep their eyes open focusing on a written sign, and 
disregard the sounds presented to them. We used three blocks of 400 binaural 80-dB stimuli (0.3 
sec inter-stimulus interval) comprising 85% standards (25 ms, 1000 Hz, 5-ms rise/fall time) and 
15% duration deviants (50 ms, 1000 Hz, 5 ms rise/fall time). MMN was extracted by subtracting 
the averaged waveforms for the standard stimuli from those for the deviant stimuli, after 
filtering (0.03–40 Hz) and baseline correction (–50 to 0 ms). Peak amplitude of the mismatch 
negativity waveform was measured at Fz, calculating the difference between mean MMN (130 
to 190ms) and MMN baseline (-50 to 0ms). 
Participants also underwent a paired-click paradigm (40, 41). S1 and S2 clicks were of 1 ms 
duration and separated by 500 ms. Intertrial intervals between click pairs were 10 seconds. 
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Subjects were presented with four or five blocks of 30 pairs of conditioning and test clicks and 
instructed to avoid blinking during the click presentations. Stimulus intensity was adjusted 
individually to 43 dB above the hearing threshold. To obtain the ERP, the EEG signal was 
filtered (10Hz high-pass filter), corrected for baseline values (–50 to 0 ms) and epochs were 
averaged separately for the first click (S1) and the second click (S2). . P50 peak amplitudes for 
S1 and S2 were measured at the Cz site, in the 50–70ms post-stimulus interval, using a 
computer algorithm. S2 P50 latency had to be a value within ± 10 ms of S1 P50 latency and P50 
amplitude was measured relative to its preceding through. S1 P50 waves with less than 0.5 μV 
were excluded. P50 ratio was calculated as S2/S1 P50. 
The three experiments were carried out in the above order, their duration was approximately 15, 
6 and 20-25 minutes, respectively. 
 
Time-frequency analyses 
Time-frequency analyses were performed using the same artifact-free data segments used in the 
ERP processing pipeline, before filtering or averaging. Power was extracted from single trials 
using the 'wavelet method' based on Morlet wavelets with a 'width' of 4 (6), 1Hz (frequency) 
and 1msec (time) resolution. The EEG frequency bands of interest were Delta (1-3Hz), Theta 
(4-7Hz), Alpha (8-12Hz), Beta (13-30Hz) and Gamma (31-100Hz). For EROs calculation, 
relative baseline correction (the quotient of post stimuli power over baseline average power) 
was applied and baseline lengths were determined separately for each band: Delta (-1000 to 0 
ms), Theta (-250 to 0 ms), Alpha (-125 to 0 ms), Beta (-100 to 0 ms), Gamma (-50 to 0 ms). 
EROs represent the relative change of spectral power in comparison to the baseline. 
 
Statistical Analysis 
Group differences for mean RT, target response accuracy and P50 S2/S1 amplitude ratios were 
tested by univariate t-test. EROs differences between groups and conditions (tow tone types) 
were analyzed using independent and dependent samples t-tests respectively and the 
associations between EROs and psychosis symptoms/oddball task reaction time (RT), were 
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analyzed using linear regression. These results were adjusted for multiple comparisons by 
means of a cluster based test statistic (for temporal and spectral adjacency) with a threshold 
alpha=0.05; Monte Carlo significance probability was calculated using 1000 random partitions, 
the maximum of the cluster-level summed t-values and a cluster threshold alpha=0.05 (42). 
EROs were measured from each of the tested paradigms, within the time-frequency boundaries 
of the clusters showing overlap between condition, oddball task reaction time (RT) and/or group 
effects (Figures 1 and 2), thus selecting EROs of interest. Because in the passive oddball 
paradigm there was no group effect on isolated EROs clusters, we included all deviant tone 
EROs clusters that were associated with the condition effect, given this functional link between 
them. This was applied equally to all subjects as follows: Oddball task EROs - target tone 
maximum EROs value, measured within the time-frequency boundaries of the delta-theta cluster 
associated with the group effect (Figure 2a). Passive oddball EROs - the ratio between mean 
deviant tone EROs within the condition effect associated gamma and theta positive clusters, and 
the minimum EROs value within the beta negative cluster boundaries (Figure 1b). Paired-click 
low frequency EROs gating - the minimum S2/S1 EROs ratio value, measured within the group 
effect associated delta-theta cluster boundaries (Figure 2d). EROs extracted from each paradigm 
were compared between groups using ANOVA, including a fixed factor for gender and age as 
covariate. Correlations between each paradigm EROs were performed, with bonferroni 
correction. An ANOVA model with an interaction term clinical group * 
passive oddball EROs
paired−click paradigm EROs gating
, as independent variable and oddball task EROs as dependent 
variable, was used to test the relationship between sensory driven and top down EROs in the 
two study groups. EROs were entered in regression analysis as independent variables, to predict 
age, illness duration, PANSS positive and negative symptoms subscales. EROs were 
transformed into zscores and combined as: oddball task + passive oddball - low frequency 









Event-related potentials and behavioral results 
The grand average ERP waveforms for patient and control groups of the P300 at Pz, MMN at Fz 
and P50/N100 at Cz, are displayed in Figures 1d, 1e and 1f respectively, with their characteristic 
form widely described in the literature. As expected from previous studies, controls showed 
significantly larger P300 and MMN amplitudes, smaller P50 ratio (Appendix Figures 2a and 2b) 
and faster RTs, there no group difference in target response accuracy (Table 1).  
Time-frequency analysis by test condition 
The condition effects (two tone types comparisons) for the 3 studied paradigms in the overall 
sample (patients and controls combined) are shown in Figures 1a-c t-test scores. Oddball task 
target tones elicited larger delta/theta frequency range and late gamma EROs, but smaller alpha 
EROs than standard tones (Figure 1a). Passive oddball deviant tones elicited larger early gamma 
and delta/theta EROs, but smaller late beta EROs than standard tones (Figure 1b). From the 
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EROs clinical group comparisons and associations with oddball task reaction time  
 
Oddball task 
T-test scores in Figure 2a show reduced target tone delta/theta EROs in patients compared to 
controls. A similar difference was found for the oddball task non-target tone (not shown). Linear 
regression coefficients in Figure 2b show three time-frequency EROs clusters, associating target 
tone EROs with RT in all subjects. As such, smaller task-related EROs in early and late gamma 
and low frequencies were markers of slower RT. Conversely, mid-latency gamma and late 
alpha/beta EROs were positively associated with RT.  
Passive oddball paradigm 
No between groups differences were found for deviant or standard tones EROs time-frequency 
spectrums. Linear regression coefficients in Figure 2c show a positive association between 
patients' deviant-standard tone late beta frequency range EROs difference and oddball task RT; 
thus, as deviant tone late beta EROs increase relative to the standard tone, RT is slower. 
Paired-click paradigm 
No between-group differences were found for S1 or S2 tone EROs time-frequency spectrums. 
T-test scores in Figure 2d show smaller S2/S1 theta EROs ratios in controls compared to 
patients. Linear regression coefficients in Figure 2e show a positive association between 
patients' S2/S1 theta EROs ratio and oddball task RT; thus, worse low frequency EROs gating is 
linked to slower RT.   
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Figure 2  
Oddball task paradigm 
a) Target tone EROs - controls Vs patients (Pz) b) Target tone EROs and reaction time (Pz) 
  
Passive oddball paradigm 
c) Deviant-Standard tone EROs and reaction time (Fz) 
 
Paired-click paradigm 
d) S2/S1 EROs ratio - controls Vs patients (Cz) e) S2/S1 EROs ratio and oddball task reaction time (Cz) 
  
Figure 2. a) T-test scores (colour scale located to the far right of the plot) for comparisons between controls Vs patients 
target tone EROs time-frequency spectrums from the oddball task, at Pz electrode. b) Linear regression coefficients for 
the association between target tone EROs time-frequency spectrum and reaction time (RT). c) Linear regression 
coefficients for the association between passive oddball (MMN) paradigm EROs difference (deviant-stantard) and RT, 
at Fz electrode. d) T-test scores for comparisons between controls Vs patients S2/S1 EROs time-frequency spectrum at 
Cz electrode. e) Linear regression coefficients for the association between S2/S1 EROs time-frequency spectrum and 
RT. EEG frequency is indicated on the y-axis and time is indicated on the x-axis; results are adjusted for multiple 
comparisons and then a mask (white colour) applied for non significant comparisons, using a significance threshold of 
p<.05. Associations between EROs and RT included all study subjects (controls and patients combined). 
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EROs groups comparisons, relationships between EROs and their associations with clinical 
variables 
EROs extracted from each of the tested paradigms were compared between groups using 
ANOVA. Patients showed deficits in the three paradigms, with significant estimated marginal 
means group effects on oddball task EROs, F(1,68)=13.99, p<0.001, passive oddball EROs, 
F(1,68)=7.20, p=0.009 and low frequency EROs gating, F(1,68)=11.18, p=0.001. Group x age 
interaction effects showed that with increasing age, low frequency EROs gating values 
decreased in the controls group, but not in the patients group (appendix Tables 1-3 and Figure 
3b). Oddball task EROs and low frequency EROs gating were correlated in the patients group (r 
= -0.45, p=0.05), there were no other significant correlations between EROs in patients or 
controls groups. The ratio 
passive oddball EROs
low frequency EROs gating
 predicted oddball task EROs in controls, 
F(1,68)=6.11, p=0.004 (β=0.55, t=2.82, p=0.006), but not in patients (β=0.21, t=0.82, p=0.41). 
Results of regression analysis looking at associations between extracted EROs and clinical 
variables are displayed in appendix Table 4. The ratio 
oddball task EROs
low frequency EROs gating
 increased with 
duration of psychosis illness (see also Figure 3c). Low frequency and high frequency EROs 
gating were independently positively associated with PANSS negative symptoms (see also 
Figure 3d). No association was found between EROs and PANSS positive symptoms. 
ROC curve using the three paradigms combined EROs as independent variable, is shown in 
Figure 3a. The area under the curve is 0.82, with SE=0.05 and 95% CI 0.72 to 0.92, at the 










































































































































































































































































































































































































































































































































































































































































































































Our results provide insights into normal brain neurophysiology and how it is impacted upon by 
psychosis. The studied EROs display a physiological pattern, marking conscious attention and 
stimulus salience attribution in the auditory oddball task and passive oddball paradigms (43). 
This pattern consists of increased EROs, first in the early gamma and then in low frequencies 
(delta/theta), a "fast-to-slow" transition (44) that has been attributed to a change from early 
sensory perception to encoding functions (45, 46), followed by attenuated EROs at higher 
frequencies (alpha to gamma). The EROs increase possibly reflects underlying excitatory brain 
activity and allocation of brain resources to stimulus processing (47). Cortical excitatory 
pyramidal neurons may then be physiologically kept in check by feedback inhibition, mediated 
by high frequency inhibitory interneurons that set firing rates back into a functional range (48, 
49).The attenuation of these inhibitory EROs could indicate a state of increased arousal or brain 
excitability (50, 51). Alpha event-related desynchronization, in particular, is thought to reflect 
attentional demands and cortex release from inhibition (52), it has previously been found 
associated to stimulus relevance evaluation in the oddball task (53) and impaired in 
schizophrenia patients (54). Within these dynamics, the functional roles of early gamma EROs, 
related to sensory processing and late gamma EROs, related to cognition (55, 56), are tapped on 
by the passive oddball and oddball task paradigms deviant and target tone effects, respectively. 
There is evidence, from studies where psychosis mimicking substances ketamine and 
dexamphetamine (57-59) were administered to healthy subjects, for an inverse association 
between higher and lower frequencies EROs. It has been proposed that, in schizophrenia, 
inhibitory inputs from GABAergic interneurons to pyramidal neurons, through gamma 
oscillations, are reduced as a downstream homeostatic response to maintain 
excitatory/inhibitory balance, in the face of impaired excitatory activity (60). Stahl (61) 
conceptualized a neurochemical schizophrenia model where dysfunctional glutamate-activated 
GABA interneurons are linked to abnormal dopaminergic activity, producing psychosis 
symptoms.  
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We found early psychosis patients showed deficits in each of the studied paradigms and also 
disrupted connection between sensory driven (passive oddball and paired-click paradigms) and 
top down (oddball task) EROs. Sensory gating increase with age may be a maturational change 
(62), that we observed in the controls group, but not in the early psychosis patients sample. 
Healthy subjects brains develop increasing efficiency, during early adulthood, resulting in lesser 
need to recruit cognitive capacity (63), whereas psychosis patients have been shown to have 
abnormal maturation of attentional performance (64). On the other hand, oddball task and low 
frequency EROs gating increased with advancing duration of psychotic illness (Figure 3c). This 
supports the possibility of a partial recovery in brain function (65, 66), following a "hit" around 
disease onset (67). Poorer low and high frequency EROs gating was associated with worse 
psychopathology in early psychosis patients, suggesting these symptoms bear relationship with 
the specific impairment of brain gating mechanisms and the extent to their improvement 
following disease onset. Our results indicate the coexistence of several processes influencing 
brain function during early psychosis: acquired deficits, disrupted maturation, but also partial 
recovery; this complexity fits with the controversies around the longitudinal course of brain 
function in psychosis (68). Previous ERP and neuropsychological studies showed a mixed 
picture, where some neurophysiological deficits progress, with increasing risk of transition to 
psychosis, whereas others do not (69-83).  
Our study has limitations: we could not perform subgroup analysis, looking at diagnostic 
specificity (84-88), due to the small numbers. Only one electrode per paradigm was analyzed, 
topographical effects and brain sources were not investigated; this approach, however, reduced 
multiple comparisons and makes data collection/analysis easier, thus facilitating potential 
translation to clinical application. We did not control for medication (5, 89) as the drugs 
prescribed were too heterogeneous, or smoking (37) effects.  
In conclusion, in early psychosis, attention function related neurophysiological markers show 
impairment, reveal disrupted brain maturation and reflect psychosis symptoms severity, but also 
indicate partial recovery in brain function. 
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PAPER 1 SUPPLEMENTARY MATERIAL 
Table 1. Oddball task EROs comparisons 
Descriptive statistics 
Group Mean SD N 
Controls 1.28 0.40 35 
Early psychosis patients 0.94 0.37 34 
Tests of between-subjects effects 
Parameter Sum Sq. d.f. Mean Sq. F Sig 
clinical group 2.06 1 2.06 13.99 <0.001 
Error 9.86 67 0.15   
Comparisons of mean group differences 




Sig. Adjusted 95% CI 
Controls Vs Early psychosis 
patients 
0.34 0.09 <0.001 0.16 to 0.53 





Table 2. Passive oddball EROs comparisons 
Descriptive statistics 
Group Mean SD N 
Controls 0.45 0.19 35 
Early psychosis patients 0.32 0.22 34 
Tests of between-subjects effects 
Parameter 'Sum Sq.' 'd.f.' 'Mean Sq.' 'F' 'Prob>F' 
'clinical group' 0.32 1 0.32 7.20 0.009 
'Error' 2.93 68 0.04   
Comparisons of mean group differences 




Sig. Adjusted 95% CI 
Controls Vs Early psychosis 
patients 
0.14 0.05 0.009 0.04 to 0.24 







Table 3. Low frequency EROs gating comparisons 
Descriptive statistics 
Group Mean SD N   
Controls -0.77 0.46 35   
Early psychosis patients -1.12 0.46 34   
Tests of between-subjects effects 
Parameter 'Sum Sq.' 'd.f.' 'Mean Sq.' 'F' 'Prob>F' 
'clinical group' * 'age' 0.84 1 0.84 4.56 0.04 
'clinical group' 0.43 1 0.43 2.36 0.13 
'age' 1.02 1 1.02 5.23 0.02 
'Error' 11.98 65 0.18   
Parameter estimates 
Parameter Β (SE) t Sig 95% CI 




-0.15 0.88 -0.04 to 0.03 
Controls * age -0.06 (0.02) -3.30 0.002 -0.09 to -0.02 
Comparisons of mean group differences 




Sig. Adjusted 95% CI 
Controls Vs Early psychosis 
patients 
-0.35 0.10 0.001 -0.56 to -0.14 
EROs gating ratio was log transformed for ANOVA comparisons. 
 
 
Table 4. Relationship between EROs, illness duration and PANSS scores 












Oddball task EROs 0.49 (< 0.01)      
Low freq. EROs gating 0.47 (< 0.01)      
  0.26 (0.28) 12.38  
(p= 0.001) 
   
(Constant) -   - 0.56 0.58 
𝐎𝐝𝐝𝐛𝐚𝐥𝐥 𝐭𝐚𝐬𝐤 𝐄𝐑𝐎𝐬
𝐋𝐨𝐰 𝐟𝐫𝐞𝐪. 𝐄𝐑𝐎𝐬 𝐠𝐚𝐭𝐢𝐧𝐠
    0.53 3.52 0.001 
PANSS negative symptomsb 
  0.51 (0.47) 15.15 (< 0.001)    
(Constant) -   - -2.09 0.04 
Low freq. EROs gating 0.54 (0.001)   0.47 3.55 0.001 
High freq. EROs gating 0.55 (0.001)   0.47 3.60 0.001 
a) Passive oddball EROs showed no significant bivariate correlation with illness duration and were excluded from 
the regression analysis.Oddball task EROs and Low fre. EROs gating were not independent predictors of illness 
duration, the ratio between the two provided the best fit in the regression model. b) oddball task and passive 
oddball EROs showed no significant bivariate correlations with PANSS negative symptoms score and did not fit 
in the regression model using this score as dependent variable. High frequency EROs gating was then entered 
together with low frequency EROs gating, the two measures independently predicting PANSS negative 













Appendix figure 1. EROs plots for the two stimuli types in each of the tested paradigms. EROs represent power 








Appendix figure 2. ERP comparisons 
a) P300 ERP (Pz) - controls Vs patients b) MMN ERP (Fz) - controls Vs patients 
  
Appendix figure 2. a) and b) P300 and MMN ERP amplitude comparisons between controls and patients, for a 
250-400 ms and a 100-250 ms post stimulus time windows, respectively. T test scores (y-axis) are displayed and 





















































































































Before each participant received their clinical assessment and EEG test, the 
following material was provided to them to read and complete: 
 
 Maudsley Family Study participant information sheet 
 Information sheet provided on day of testing 
 Consent form one - consent to take part 




















PATIENT INFORMATION SHEET 
 
MAUDSLEY FAMILY PSYCHOSIS STUDY 
 
You are invited to take part in a new research project at the Institute of Psychiatry.  
 
Why have I been contacted? 
This research is a continuation of the Maudsley Family Psychosis Study, which has investigated brain 
structure and function in people with psychosis and their relatives. 
 
Before you decide to take part it is important that you understand why the research is being done and 
what it involves. Please read through this information sheet carefully. You may like to discuss this 
research with friends or family. Please feel free to contact us if you have any questions. 
 
Why are we doing this research? 
This study seeks to find out more about the genes that are involved in predisposing to schizophrenia and 
the way in which these relate to the functioning of the brain.  We do this by comparing brain structure and 
function of people with schizophrenia to that of their relatives and to members of the general population. 
We hope that our research will help future treatments and lead to an earlier diagnosis of schizophrenia. 
 
Do I have to take part? 
Participation in the study is entirely voluntary.  If you do not wish to participate in the study, any care that 
you are receiving will not be affected. If you agree to take part in this study and later wish to withdraw, 
you may do so at any time without giving a reason. If you decide to withdraw, your future treatment will 
not be affected.  
 
If you would be happy to take part, then you will be given a copy of this information sheet, and we will 
ask you to sign a consent form. 
 
How long will it take? 
We would like you to come to the Institute of Psychiatry in London, on a date which is convenient for 
you. Typically you would only need to come to London to see us once. The research would be completed 
within one day. We are also very happy for you to take part in the research with other family members on 







We will reimburse all travel expenses and provide refreshments while you are here.  We will also cover 
any other expenses incurred due to participation in the study, such as overnight accommodation or child 
care. We also provide further compensation for any inconvenience caused.   
 
Many thanks for taking the time to consider taking part. Next is an explanation of what is involved in this 
research study. 
 
(1) EVOKED POTENTIALS: 
Evoked Potentials (EPs) are aimed to record brain electrical activity in order to understand more about 
brain function. They are based in a test called EEG (Electroencephalogram) that is done routinely in most 
hospitals. It is also similar to an ECG test, only leads are attached to the head instead of the chest. The 
procedure involves attaching some leads on your head to record the electrical waves that naturally take 
place in the brain.  We will look at how your brain activity changes when you listen to sounds. This test 
takes about 2 hours. It does not involve any radiation and cannot hurt you in any way. 
 
(2) DNA: A cheek swab or blood sample is taken for genetic testing. DNA or hereditary material is 
extracted from the blood and is added to a panel of several other samples, which are then examined to see 
if we can identify genes that contribute to schizophrenia. We are interested in how specific genes affect 
how the brain functions and the structure that it has. There is no individual result from this test. 
 
(3) PSYCHOLOGICAL INTERVIEW: The interview will concentrate on your past medical history 
and how any psychological symptoms developed over time. It lasts for about one hour. 
 
What are the possible benefits of taking part? 
There will be no immediate benefit to you from this project but we hope it will increase our 
understanding of how the brain functions in schizophrenia and the role of certain genes. In this way, we 
hope to improve the future treatment and early diagnosis of schizophrenia.  
 
Confidentiality 
The measurements from the various tests will be combined with those from other participants and 
analysed on computers at the Institute of Psychiatry. All results of the tests are absolutely confidential and 
are protected by the Data Protection Act. There will be no specific ‘results’ from your tests so you will 
not be contacted in the future, although we can provide general information on our progress and research.  
If, during the course of this project, we obtain information that will be clinically important, we will seek 
your approval to contact your GP. 
 
Complaints 
If you have a concern about any aspect of this study, you should ask to speak with the researchers who 
will do their best to answer your questions (020 7848 0565).  If you remain unhappy and wish to 
complain formally, you can do this through The Joint South London and Maudsley and the Institute of 







In the extremely unlikely event that something does go wrong during this research project and you are 
harmed you may have grounds for a legal action for compensation against King’s College London. 
 
What will happen to the results from the research? 
You will be kept informed of the progress of the Maudsley Family Psychosis Study research by the 
regular sending of newsletters. Any results from the current study will be communicated to other health 
professionals and researchers through conference presentations and academic journals. Participants will 
not be identifiable in any research publications. 
 
Ethical Approval 
The Joint South London and Maudsley and the Institute of Psychiatry Research Ethics committee have 
reviewed this research and given ethical approval. 
 
Many thanks for reading this information sheet. We hope that you will agree to take part. 
 
Contact Details 
If you would like to take part or if you have any questions, please contact Miguel Constante. 
 
Post : Miguel Constante           
Division of Psychological Medicine       
 P063           
 Institute of Psychiatry 
  De Crespigny Park         
 London, SE5 8AF                                      
Phone: +4407904413299                     











A STUDY OF BRAIN FUNCTION USING EEG SCANS 
 
You have been asked here to take part in a study conducted by Miguel Constante, Ian Williams, Madiha 
Shaikh, Dr. Elvira Bramon and Prof. Robin Murray. We are hoping to learn more about mental 
functioning in health and in those living with psychological illness. We would like to invite you to take 
part in the following tests.  
 
CLINICAL INTERVIEW 
This is a standard medical interview. You will be asked you about your past medical history and how any 
psychological symptoms developed over time. It lasts about one hour. 
 
EEG TEST 
This test involves recording electrical waves that occur naturally in the brain. It is like an ECG test for the 
heart, only in this case leads are attached to the head instead of the chest. We will do the EEG whilst you 
are doing a series of simple tasks which involve listening to tones through earphones and responding to 




A blood sample is taken for genetic testing. DNA or hereditary material is extracted from the blood and is 
added to a panel of several other samples. Then they are examined to see if we can identify genes that 
contribute to mental disorders. There is no individual result from this test. The DNA you donate will be 
stored in our laboratory as an anonymous sample (with a code, not with your name). This will allow us to 
do further studies in the future keeping up with developments in the field. Every future study will have to 
be approved by the Ethical Committee. The blood test only takes a couple of minutes. 
 
Finally, please take this into account: You have the right to choose whether or not you want to participate 
in this project. There will be no immediate benefit to you from this project but it may prove of benefit in 
the understanding of how the brain functions in psychological illness. Participation in the study is entirely 
voluntary. If you agree to take part in this study and later wish to withdraw, you may do so at any time 
without giving a reason. The results of the test are confidential and are protected by the Data Protection 
Act. You will not be identified in our computer by name but by a number. The results will only be used to 
understand more about mental functioning in people living with psychological problems. 














A STUDY OF BRAIN FUNCTION IN PSYCHOSIS 
CONSENT FORM 
 
I     _________________________________________________ 
(Please print name in capital letters) 
 
 




(Please write address in capital letters) 
 
have read the information sheet for the above research project. 
 
I understand the purpose of the project and that I am perfectly free to take part or not as I wish. The 
research project has been explained to me and all my questions answered to my satisfaction. 
 
In light of what I have now been told, I freely consent to take part in the research project. 
 








Signature of participant:    ______________________________ 
Date: _______________________________________________
  








Any information that you give will be treated as strictly confidential 
 
Name: 
Date of Birth: Today’s date: 
 
Please circle your handedness: 
 
Right handed / left handed / use both hands 
 
Please list any medications that you take on a regular basis 
 







Please tick your completed level of education: 
None   
GCSE’s / O-Levels  
GNVQ / B-TEC  
AS Levels / A1  
A Levels / A2   
Degree  
Post Graduate Degree  
Other (Please Specify)  
 
 


















Substance Use Questionnaire 
Tobacco 
How many cigarettes a day do you smoke currently? 
 
At what time did you smoke your last cigarette today? 
 
What is your average daily number over the last month? 
 
How many years have you been smoking for? 
 
Cannabis 
When did you smoke cannabis for the last time? 
 
What is the average you take in one day currently? 
(Number of joints per day) 
Alcohol 
What is the average amount of alcohol you take per day? 
(You can use units or explain the number of glasses of each drink) 
 
How much per day during the working week? 
 























     
Solvents 
(glue) 





























This appendix supplements the methodology section (Chapter Two) and aims to provide 
fuller and more specific details regarding the methods of EEG data collection.  
 
A2.1 Data collection – general laboratory information 
New EEG recordings undertaken as part of my own data collection were carried out at 
the Neurophysiology Laboratory in the Psychosis Centre of the Institute of Psychiatry, 
King’s College London. The EEG recordings of previously collected data by my 
colleagues and which were also used in this thesis, were carried out in the 
Electrophysiology Laboratory inside The Eric Byers Magnetic Resonance Suite of 
Mapother House, King’s College Hospital. The move between labs took place in 
February 2007. 
The stimuli for each paradigm did not change between the laboratories and were 
generated and presented in the same manner, using the STIM stimulus presentation 
system (Compumedics Neuroscan, Texas, USA) though intra-aural earphones (ER3-14A 
Eartips for ER-3 and ER-5, Etymotic Research Inc. Illinois, USA). The 
electroencephalogram (EEG) was recorded using the SCAN software package 
(Compumedics Neuroscan, Texas, USA) and in 2007 the software was updated from 
version 4.2 to version 4.3.  
In the Mapother House laboratory a 64-channel SynAmps® (Model 5083) amplifier was 
used, while in the Psychosis Centre the SynAmps® was upgraded to the SCAN NuAmps 
ExpressTM 40-channel monopolar digital amplifier (pictured on the right of figure A3). 
The NuAmps was quicker and easier to set up for recording, which proved to be 
especially advantageous when dealing with participants who were particularly unwell or 





In the Mapother House neurophysiology laboratory data were collected using a 64-
channel EEG Quik-Cap fitted with silver/silver-chloride electrodes (Compumedics 
Neuroscan, Texas, USA) referenced to the mastoids and positioned according to the 
10/20 International System. In spring 2007 the move to the Psychosis Centre and the 
NuAmps system necessitated the use of a 40-channel Quik-Cap. The channel layouts of 
these two caps can be seen in figures A1 and A2, and the referencing to linked mastoids 
used in the new laboratory can be seen on the left of figure A3. 
 
Figure A1: Layout of 40 channel Quik-Cap 
 






Figure A3: EEG referencing 
 
In all recordings FPZ (mid-forehead) served as ground and impedances were kept below 
5 kΩ at all sites with the use of conductive gel (ECI ElectrogelTM, Electro-Cap 
International Inc. Ohio, USA). A small amount of gel was applied to the scalp through 
holes in each electrode using 10 ml syringes (BD 10 ml Syringe with Luer-LokTM tip, 
Becton Dickson & Co., NJ, USA) fitted with blunt needles (BD 16G¾ Blunt Square 
Grind PrescisionGlide® Needle, Becton Dickson & Co., NJ, USA). The needles were 
then used to gently manipulate the hair until the impedance at each electrode fell below 




required before commencing testing can be seen below in figure A4. This process would 
usually take around ten minutes to complete. 
 
Figure A4: Impedance screens: before and after preparation shots  
 
Monitoring of the blinks and eye movement was achieved by recording of 
electromyographic (EMG) activity from electro-oculogram (EOG) electrodes placed at 
four locations (the outer canthus of each eye, and above and below the right eye over 
the orbicularis oculi) as shown in figure seventy-three. With the 64-channel cap VEOGU 
and VEOGL (the upper and lower vertical electro-oculogram electrodes) were placed 
above and below the right eye, and HEOGL and HEOGR (left and right horizontal 
electro-oculogram electrodes) to the outer canthus of the left and right eyes respectively. 
With the 40-channel Quik-Cap, electrodes X1 and X2 were placed above and below the 
right eye respectively, while X3 and X4 were placed to the left and right of the eyes.  




RIGHT EYE CHANNEL 
(HEOGR/X4)
 





To prepare the areas on the face and mastoids for the placement of electrodes, abrasive 
gel was gently applied to the skin (NuPrep Abrasive Skin Prepping Gel, D.O Weaver 
and Co., Colorado, USA), and this was then cleansed with an alcohol swab (70% 
Isopropyl Alcohol Alcotip Swab, Universal Hospital Supplies Ltd., UK). This process 
reduces the impedance between skin surface and conductive gel by removing makeup, 
skin oil and dead skin cells. As with the cap electrodes, with the reference and EOG 
electrodes impedances below 5 kΩ were required. 
Each recording session lasted approximately 45 minutes and the neurophysiological 
paradigms were carried out in a fixed order: 1st - paired-clicks, 2nd auditory oddball task 
and 3rd. passive oddball (these were followed by recording of the resting EEG and PPI 
paradigm, which were not subject of study in this thesis). Participants were seated in a 
comfortable chair throughout. They were asked to sit as still and quietly as possible, to 
keep their eyes open and to concentrate on the task at hand. It was also ensured that the 
patient was not chewing gum during testing to avoid muscle artefacts in the recording. 
Before setting up the EEG cap the participant was talked through what to expect from 
the session in detail, allowed to examine the cap and gel, and was given ample 
opportunity to ask any questions. They then gave informed written consent on the form 
shown in appendix one (sections A1.3).  
 
A2.2 Differences in data collection between the two labs involved 
While I personally collected data from only one laboratory, this thesis includes data 
collected in one other laboratory and using slightly different data collection techniques. 
A detailed survey of data collection methodology for the sensory gating, passive oddball 




The change reflected the continuous updating of the amplifier and the version of the 
SCAN software used. The high pass filter on the previous amplifier would only go as 
far as 0.05 Hz, but the most recent NuAmps amplifier can handle DC so this was 
chosen. Other points such as the references used and the filters applied during collection 
are relatively minor and in no way affect the compatibility of the continuous EEG data.  
With all the EEG paradigms studied here, while all data are fully compatible, 
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